KR810000003B1 - Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones - Google Patents

Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones Download PDF

Info

Publication number
KR810000003B1
KR810000003B1 KR7502005A KR750002005A KR810000003B1 KR 810000003 B1 KR810000003 B1 KR 810000003B1 KR 7502005 A KR7502005 A KR 7502005A KR 750002005 A KR750002005 A KR 750002005A KR 810000003 B1 KR810000003 B1 KR 810000003B1
Authority
KR
South Korea
Prior art keywords
thiadiazol
methyl
pyrimidinone
reaction mixture
tetrahydro
Prior art date
Application number
KR7502005A
Other languages
Korean (ko)
Inventor
크렌저 죤
Original Assignee
로버트 제이 슈와르츠
벨시콜 케미칼 코오포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로버트 제이 슈와르츠, 벨시콜 케미칼 코오포레이숀 filed Critical 로버트 제이 슈와르츠
Priority to KR7502005A priority Critical patent/KR810000003B1/en
Application granted granted Critical
Publication of KR810000003B1 publication Critical patent/KR810000003B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1-Thiadiazolyl-6-acyloxytetrahydropyrimidinones (I; R1 = alkyl, alkenyl, haloalkyl, alkoxy, alkylthio, alkylsulfonyl, alkylsulfinyl or cycloalkyl; R2 = alkyl, alkenyl, haloalkyl; R6 = alkyl, haloalkyl, alkenyl, alkinyl, alkoxyalkyl, cycloalkyl; X = alkyl, halogen, haloalkyl, nitro, cyano, alkoxy; m, n = O-3; R7, R8 = methyl, ethyl), useful as herbicide, were prepd. by reaction of compd. (II) and acid anhydride (III) in the presence of toluene sulfonic acid at 50-90≰C. The reaction of compd. (II) and (IV) at 10-30≰C also give title compound.

Description

1-티아디아졸릴-6-아씰록시 테트라 하이드로 피리미딘온의 제조방법Method for preparing 1-thiadiazolyl-6-acyloxy tetrahydro pyrimidinone

본 발명은 일반식(I)로 표시되는 새로운 화합물의 제조방법에 관한 것이다.The present invention relates to a method for preparing a new compound represented by formula (I).

Figure kpo00001
Figure kpo00001

상기 식에서, R1은 알킬, 알케닐, 할로알킬, 알콕시, 알킬티오, 알킬술포닐, 알킬술피닐 또는 싸이클로 알킬이고, R2은 알킬, 알케닐, 할로알킬 도는

Figure kpo00002
(여기서 R4및 R5는 각각 수소 또는 알킬이다)이며 R3은 수소 또는
Figure kpo00003
이고 R6는 알킬, 할로알킬, 알케닐, 알키닐, 알콕시알킬, 싸이클로알킬 또는
Figure kpo00004
(여기서 X는 알킬, 수소, 할로알킬, 니트로, 씨아노 또는 알콕시, m과 n은 각각 0-3의 정수이다)이다.Wherein R 1 is alkyl, alkenyl, haloalkyl, alkoxy, alkylthio, alkylsulfonyl, alkylsulfinyl or cycloalkyl, R 2 is alkyl, alkenyl, haloalkyl or
Figure kpo00002
Wherein R 4 and R 5 are each hydrogen or alkyl, and R 3 is hydrogen or
Figure kpo00003
And R 6 is alkyl, haloalkyl, alkenyl, alkynyl, alkoxyalkyl, cycloalkyl or
Figure kpo00004
Wherein X is alkyl, hydrogen, haloalkyl, nitro, cyano or alkoxy, m and n are each an integer of 0-3.

본 발명을 더 구체적으로 설명하면, R1은 저급알킬, 저급알케닐, 저급클로로알킬, 저급브로모알킬, 트리플루오메틸, 저급알콕시, 저급알킬티오, 저급알킬술포닐, 저급알킬술피닐 또는 탄소원자 3-7의 싸이클로 알킬이고, R2는 저급알킬, 저급알케닐, 저급싸이클로알킬, 저급브로모알킬 또는

Figure kpo00005
(여기서 R4및 R5는 각각 수소 또는 저급알킬이다)이고 R3은 수소 또는
Figure kpo00006
이며 R6은 저급알킬, 저급클로로알킬, 저급브로모알킬, 저급알키닐, 저급알톡시알킬, 탄소원자 3-7의 싸이클로알킬 또는 -(CH2)m
Figure kpo00007
(여기서 X는 저급알킬, 저급알콕시, 수소 또는 저급할로알킬이고 m과 n은 각각 0-3의 정수이다)을 나타낸다. 여기에서 사용되는 "저급"이란 탄소원자 6까지의 직쇄 또 측쇄 탄소결합을 의미한다.In more detail the present invention, R 1 is lower alkyl, lower alkenyl, lower chloroalkyl, lower bromoalkyl, trifluoromethyl, lower alkoxy, lower alkylthio, lower alkylsulfonyl, lower alkylsulfinyl or carbon Cycloalkyl of atoms 3-7, R 2 is lower alkyl, lower alkenyl, lower cycloalkyl, lower bromoalkyl or
Figure kpo00005
Wherein R 4 and R 5 are each hydrogen or lower alkyl and R 3 is hydrogen or
Figure kpo00006
And R 6 is lower alkyl, lower chloroalkyl, lower bromoalkyl, lower alkynyl, lower alkoxyalkyl, cycloalkyl of 3-7 carbon atoms or-(CH 2 ) m
Figure kpo00007
Wherein X is lower alkyl, lower alkoxy, hydrogen or lower haloalkyl and m and n are each an integer of 0-3. As used herein, "lower" means a straight or branched carbon bond of up to 6 carbon atoms.

본 발명의 화합물은 예상대로 제조제로서 유용하다. R3

Figure kpo00008
이고 R6가 전술한 바와같은 본 발명의 화합물은 R3이 수소인 일반식(II)로 표시되는 상응하는 본 발명의 화합물을 톨루엔 술론산의 촉매량존재하에서 일반식(III)으로 표시되는 산무수물로 반응시켜서 제조된다.The compounds of the present invention are useful as preparations as expected. R 3 is
Figure kpo00008
And R 6 is a compound of the present invention wherein the compound of the present invention represented by formula (II) wherein R 3 is hydrogen is an acid anhydride represented by formula (III) in the presence of a catalytic amount of toluene sulfonic acid. It is prepared by reacting with.

Figure kpo00009
Figure kpo00009

상기 식에서 R1및 R2은 전술한 바와같다.Wherein R 1 and R 2 are as described above.

Figure kpo00010
Figure kpo00010

상기 식에서, R6는 전술한 바와같다.In the above formula, R 6 is as described above.

이 반응은 불활성 유기반응매질 존재하에 상온에서 반응물질과 촉매를 결합시킨다음 반응혼합물을 증기 욕상에서 50-90℃의 온도로

Figure kpo00011
시간동안 교반하면서 가열하는 것이 효과적이고 반응혼합물 냉각시켜 원하는 생성물이 침전되면 여과에 의하여 회수하고 또는 그속에 용해되었다면 유기반응매질을 증발시켜서 회수할 수 있다.This reaction combines the reactants and the catalyst at room temperature in the presence of an inert organic reaction medium and then the reaction mixture is brought to a temperature of 50-90 ° C. in a steam bath.
Figure kpo00011
Heating with stirring over time is effective and the reaction mixture can be cooled and recovered by filtration if the desired product precipitates or by evaporation of the organic reaction medium if dissolved therein.

어떤 경우에는 반응매질로서 불활성용매를 사용하지 않고 일반식(R)화합물의 용매로서 산무수물을 사용할 수 있다. 저급알카논 무수물을 사용할때는 물을 반응혼합물에 첨가하여 반응완료후 원하는 생성물을 침전시킬 수 있다. 생성물은 재결정등과 같은 통상방법에 의하여 정제된다.In some cases, an acid anhydride can be used as a solvent of the general formula (R) compound without using an inert solvent as the reaction medium. When using lower alkanone anhydride, water can be added to the reaction mixture to precipitate the desired product after completion of the reaction. The product is purified by conventional methods such as recrystallization.

R3

Figure kpo00012
인 본 발명의 화합물은 3급 아민과 같은 산수용체의 존재하에 일반식(II)로 표시되는화합물을 일반식(IV)로 표시되는 산할라이드와 반응시켜 제조할 수 있다.R 3 is
Figure kpo00012
The compound of the present invention may be prepared by reacting a compound represented by the general formula (II) with an acid halide represented by the general formula (IV) in the presence of an acid acceptor such as a tertiary amine.

Figure kpo00013
Figure kpo00013

상기 식에서, R6은 전술한 바와같다.In the above formula, R 6 is as described above.

이 제조방법은 일반식(III)의 원하는 무수물이 이용될 수 없을때에 이용될 수 있다. 이 반응은 산수용체의 존재에서, 약 10-30℃의 온도에서 불활성 유기용매에 용해된 등몰량의 일반식(II)로 표시되는 화합물의 용액에 일반식(IV)의 산염화물을 교반하면서 천천히 첨가하는 것이 효과적이다. 첨가가 완료된후 반응혼합물은 그 반응이 확실히 완료되게 하기 위하여 혼합물의 환류온도까지의 도도로 가열한다. 그후 원하는 생성물은 그속에 용해되어 있다면 우선 반응혼합물을 여과하여 산수용체염화물을 제거시키고 용매를 제거하거나 침전상태라면 여과하고 세척 및 정제하여 회수할 수 있다. R3이 수소인 본 발명의 화합물은 일반식(V)로 표시되는 화합물을 약 10-60분동안 희석된 수성 산성 반응매질에서 가열하므로서 제조된다.This preparation method can be used when the desired anhydride of formula (III) cannot be used. This reaction is slowly added while stirring the acid chloride of formula (IV) to a solution of the compound represented by formula (II) in an equimolar amount dissolved in an inert organic solvent at a temperature of about 10-30 ° C. in the presence of an acid acceptor. It is effective. After the addition is complete, the reaction mixture is heated to a degree up to the reflux temperature of the mixture to ensure that the reaction is complete. After that, if the desired product is dissolved in it, the reaction mixture can be filtered first to remove the acid acceptor chloride and the solvent is removed or, if precipitated, filtered, washed and purified. Compounds of the invention wherein R 3 is hydrogen are prepared by heating the compound represented by formula (V) in an aqueous acidic reaction medium diluted for about 10-60 minutes.

Figure kpo00014
Figure kpo00014

상기 식에서, R1및 R2는 전술한 바와같고 R7및 R8은 메틸 또는 에틸이다. 온도는 70℃에서 반응 혼합물의 환류온도까지가 이용된다. 반응매질은 약 0.5-5%농도 염산과 같은 희석된 무기산 수용액으로 이루어진다. 반응완료후 생성물은 반응혼합물을 냉각시키므로서 침전물로서 회수될 수 있으며 이 생성물은 그대로 또는 재결정과 같은 통상의 방법에 의하여 더 정제하여 사용할 수 있다. 일반식(IV)로 표시되는 화합물은 일반식(VI)의 이소시아네이트 이량체의 1몰량을 약 2몰의 일반식(VII)로 표시되는 아세탈과 반응시키므로서 제조될 수 있다.Wherein R 1 and R 2 are as described above and R 7 and R 8 are methyl or ethyl. The temperature is used from 70 ° C. up to the reflux temperature of the reaction mixture. The reaction medium consists of an aqueous solution of dilute inorganic acid, such as hydrochloric acid at a concentration of about 0.5-5%. After completion of the reaction, the product can be recovered as a precipitate by cooling the reaction mixture, which can be further purified or used by conventional methods such as recrystallization. The compound represented by general formula (IV) can be prepared by reacting 1 molar amount of the isocyanate dimer of general formula (VI) with about 2 moles of acetal represented by general formula (VII).

Figure kpo00015
Figure kpo00015

상기 식에서, R1은 전술한 바와같다.Wherein R 1 is as described above.

Figure kpo00016
Figure kpo00016

상기 식에서, R2, R7및 R8은 전술한 바와같다.Wherein R 2 , R 7 and R 8 are as described above.

이 반응은 반응혼합물의 환류온도로 벤젠 같은 불활성 유기 반응매질내에서 이소시아네이트 이량체와 아세탈혼합물을 가열하여 수행될 수 있다. 환류온도에서의 가열은 반응이 완결되도록 약 2-30분간 계속한 다음 원하는 생성물은 반응매질을 증발하여 회수할 수 있고 그대로 또는 통상 기술에 의하여 더 정제하여 사용할 수 있다.This reaction can be carried out by heating the isocyanate dimer and acetal mixture in an inert organic reaction medium such as benzene at the reflux temperature of the reaction mixture. Heating at reflux is continued for about 2-30 minutes to complete the reaction and then the desired product can be recovered by evaporation of the reaction medium and can be further purified or used by conventional techniques.

일반식(VI)의 이소시아 네이트이량체는 일반식(VII)로 표시되는 티아디아졸을 포스겐과 반응시켜 제조할 수 있다.The isocyanate dimer of general formula (VI) can be prepared by reacting thiadiazole represented by general formula (VII) with phosgene.

Figure kpo00017
Figure kpo00017

상기 식에서, R1은 전술한 바와같다. 이 반응은 에틸아세테이트와 같은 유기용매에 포화된 포스겐용액에 에틸아세테이트와 같은 적당한 유긴용매에 넣은 티아디아졸의 슬러리 또는 용액을 첨가하는 것이 효과적이다. 생성된 혼합물은 실온에서 4-24시간동안 교반한다. 반응혼합물에 질소가스를 불어넣은 미반응 포스겐을 제거시킨다. 원하는 생성물은 침전과 같은 것이 생성되었다면 여과에 의하여 회수하거나 그속에 용해되었다면 사용된 유기용매를 증발시켜 회수한다. 이 생성물은 그대로 사용하거나 또는 원한다면 더 정제할 수 있다.Wherein R 1 is as described above. This reaction is effective to add a slurry or solution of thiadiazole in a suitable organic solvent such as ethyl acetate to a phosgene solution saturated in an organic solvent such as ethyl acetate. The resulting mixture is stirred at room temperature for 4-24 hours. Nitrogen gas is blown into the reaction mixture to remove unreacted phosgene. The desired product is recovered by filtration if something like precipitation is produced or by evaporation of the organic solvent used if dissolved in it. This product can be used as is or further purified if desired.

본 발명의 화합물을 제조하는데 유용한 일반식(VIII)로 표시되는 티아디아졸의 예를들면 5-메틸-2-아미노-1,3,4-티아디아졸,-5-에틸-2-아미노-1,3,4-티아디아졸,5-프로필-2-아미노-1,3,4-티아디아졸, 5-아틸-2-아미노-1,3,4-티아디아졸, 5-크로로메틸-2-아미노-1,3,4-티아디아졸, 5-β크로로에틸-2-아미노-1,3,4-티아디아졸, -2-γ-크로로프로필-2-아미노-1,3,4-티아디아졸, 5-트리크로로메틸-2-아미노-1,3,4-티아디아졸, 5-메톡시-2-아미노-1,3,4-티아디아졸, 5-에톡시-2-아미노-1,3,4-티아디아졸, 5-프로폭시-2-아미노-1,3,4-티아디아졸, 5-부틸옥시-2-아미노-1,3,4-티아디아졸, 5-헥실옥시-2-아미노-1,3,4-티아디아졸, 5-메틸티오-2-아미노-1,3,4-티아디아졸, 5-에틸티오-2-아미노-1,3,4-티아디아졸, 5-프로필티오-2-아미노-1,3,4-티아디아졸, 5-부틸티오-2-아미노-1,3,4-티아디아졸, 5-메틸설포닐-2-아미노-1,3,4-티아디아졸, 5-에틸설포닐-2-아미노-1,3,4-티아디아졸, 5-부틸설포닐-2-아미노-1,3,4-티아디아졸, 5-메틸설피닐-2-아미노-1,3,4-티아디아졸, 5-에틸설포닐-2-아미노-1,3,4-티아디아졸, 5-프로필설피닐-2-아미노-1,3,4-티아디아졸, 5-t-부틸-2-아미노-1,3,4-티아디아졸, 5-트리플로로메틸-2-아미노-1,3,4-티아디아졸, 5-싸이크로프로필-2-아미노-1,3,4-티아디아졸, 5-싸이크로부틸-2-아미노-1,3,4-티아디아졸, 5-싸이크로펜틸-2-아미노-1,3,4-티아디아졸, 5-싸이크로헥실-2-아미노-1,3,4-티아디아졸, 5-싸이크로헵틸-2-아미노-1,3,4-티아디아졸, 등과 같은 것이 있다.Examples of the thiadiazoles represented by the general formula (VIII) useful for preparing the compounds of the present invention include 5-methyl-2-amino-1,3,4-thiadiazole, -5-ethyl-2-amino- 1,3,4-thiadiazole, 5-propyl-2-amino-1,3,4-thiadiazole, 5-acetyl-2-amino-1,3,4-thiadiazole, 5-chloro Methyl-2-amino-1,3,4-thiadiazole, 5-β chloroethyl-2-amino-1,3,4-thiadiazole, -2-γ-chromopropyl-2-amino- 1,3,4-thiadiazole, 5-trichloromethyl-2-amino-1,3,4-thiadiazole, 5-methoxy-2-amino-1,3,4-thiadiazole, 5-ethoxy-2-amino-1,3,4-thiadiazole, 5-propoxy-2-amino-1,3,4-thiadiazole, 5-butyloxy-2-amino-1,3 , 4-thiadiazole, 5-hexyloxy-2-amino-1,3,4-thiadiazole, 5-methylthio-2-amino-1,3,4-thiadiazole, 5-ethylthio 2-amino-1,3,4-thiadiazole, 5-propylthio-2-amino-1,3,4-thiadiazole, 5-butylthio-2-amino-1,3,4-thia Diazole, 5-methylsulfonyl-2-amino-1 , 3,4-thiadiazole, 5-ethylsulfonyl-2-amino-1,3,4-thiadiazole, 5-butylsulfonyl-2-amino-1,3,4-thiadiazole, 5 -Methylsulfinyl-2-amino-1,3,4-thiadiazole, 5-ethylsulfonyl-2-amino-1,3,4-thiadiazole, 5-propylsulfinyl-2-amino-1 , 3,4-thiadiazole, 5-t-butyl-2-amino-1,3,4-thiadiazole, 5-trifluoromethyl-2-amino-1,3,4-thiadiazole, 5-cyclopropyl-2-amino-1,3,4-thiadiazole, 5-cyclobutyl-2-amino-1,3,4-thiadiazole, 5-cyclopentyl-2-amino- 1,3,4-thiadiazole, 5-cyclohexyl-2-amino-1,3,4-thiadiazole, 5-cycloheptyl-2-amino-1,3,4-thiadiazole, And the like.

일반식(VII)으로 표시되는 아세탈이 쉽게 구할수 없을때는 일반식(IX)으로 표시되는 아민은 β-브로모프로피온 알데 하이드의 디메틸 아세탈 또는 디에틸 아세탈과 반응시켜 제조할 수 있다.When the acetal represented by formula (VII) is not readily available, the amine represented by formula (IX) can be prepared by reacting with dimethyl acetal or diethyl acetal of β-bromopropion aldehyde.

Figure kpo00018
Figure kpo00018

상기 식에서, R2는 전술한 바와 같다.In the above formula, R 2 is as described above.

이 반응은 일반식(IX)으로 표시되는 아민의 1-2몰량을 메타놀과 같은 불활성 유기반응 매질에 용해된 등몰비의 β-브로모 프로피온알데 하이드의 아세탈 1몰량과 혼합하여 수행할 수 있다. 반응혼합물을 환류 온도에서 4-8시간동안 가열한 다음 상온까지 냉각시키고 알카리금속 하이드록사이드 또는 카보네이트를 충분량 첨가하여 반응혼합물을 중화시키고 상온에서 24시간 까지 계속 교반하여 반응을 완결시키고 반응 혼합물을 여과한 다음 여액을 감압하에서 증류하면 원하는 생성물이 생성된다.This reaction can be carried out by mixing 1-2 molar amounts of the amine represented by the general formula (IX) with 1 molar amount of acetal of β-bromo propionaldehyde in an equimolar ratio dissolved in an inert organic reaction medium such as methanol. The reaction mixture is heated at reflux for 4-8 hours, then cooled to room temperature and neutralized by adding sufficient alkali metal hydroxide or carbonate to complete the reaction by stirring at room temperature for 24 hours to complete the reaction and filtration of the reaction mixture. The filtrate is then distilled off under reduced pressure to yield the desired product.

일반식(IX)으로 표시되는 화합물의 예를들면 메틸아딘, 에틸아민, 프로필아민, 이소프로필아민,

Figure kpo00019
-부틸아민,
Figure kpo00020
-부틸아민, 펜틸아민, 헥실아민, 아릴아민, 프로파길아민, 2-부텐일아민, 3-부텐일아민, 3-펜텐일아민, 4-펜텐일아민, 5-헥실일아민, 1-메틸-2-프로피닐아민, 1,1,-디메틸-2-프로피닐아민, 1-에틸-2-프로피닐아민, 1,1-디에틸-2-프로피닐아민, 1-프로피닐-2-프로피닐아민, 1,1-디프로필-2-프로피닐아민, 1-코로로아릴아민, 1-브로모아릴아민, 4-크로로-2-부텐일아민, 6-크로로-4-헥센일아민 등이 있다.Examples of the compound represented by the general formula (IX) include methyl adine, ethylamine, propylamine, isopropylamine,
Figure kpo00019
Butylamine,
Figure kpo00020
Butylamine, pentylamine, hexylamine, arylamine, propargylamine, 2-butenylamine, 3-butenylamine, 3-pentenylamine, 4-pentenylamine, 5-hexylylamine, 1-methyl -2-propynylamine, 1,1, -dimethyl-2-propynylamine, 1-ethyl-2-propynylamine, 1,1-diethyl-2-propynylamine, 1-propynyl-2- Propynylamine, 1,1-dipropyl-2-propynylamine, 1-corroarylamine, 1-bromoarylamine, 4-chloro-2-butenylamine, 6-chloro-4-hex Selenamine.

일반식(III)으로 표시되는 적당한 산무수물의 예를들면 초산무수물, 프로피온무수물, 펜탄무수물, 헥산무수물, 아크릴무수물, 부텐무수물, 펜텐무수물, 염화초산무수물, 브로모초산무수물, β-크로부탄무수물, 싸이크로헥실 카복시무수물, 벤조익무수물, 토루익무수물, 4-크로로벤조익 무수물, 3-브로모벤조익무수물, 4-플로로벤조익 무수물, 4-메톡시벤조익 무수물, 4-에톡시벤조익 무수물, 4-크로로메틸벤조익 무수물, 4-트리플로로메틸벤조익 무수물, 3,4,5-트리크로로벤조익 무수물, 페닐 아세틱무수물, 4-메틸페닉아세탈 무수물, β-페닐프로피온 무수물, γ-페닐부탄 무수물, 프로피노익 무수물, 부티노익 무수물, 메톡시 아세틱 무수물, β-메톡시 프로피온 무수물, γ-에톡시 부타노익 무수물, 등이 있다.Examples of suitable acid anhydrides represented by general formula (III) include acetic anhydride, propionic anhydride, pentane anhydride, hexane anhydride, acrylic anhydride, butene anhydride, pentene anhydride, chloride acetate anhydride, bromoacetic anhydride, β-crobutane anhydride , Cyclohexyl carboxy anhydride, benzoic anhydride, toruic anhydride, 4-chlorobenzoic anhydride, 3-bromobenzoic anhydride, 4-fluorobenzoic anhydride, 4-methoxybenzoic anhydride, 4-ethoxybenzo Ik anhydride, 4-chloromethylbenzoic anhydride, 4-trifluoromethylbenzoic anhydride, 3,4,5-trichlorobenzoic anhydride, phenyl acetic anhydride, 4-methylphenic acetal anhydride, β-phenylpropion Anhydride, γ-phenylbutane anhydride, propinoic anhydride, butinoic anhydride, methoxy acetic anhydride, β-methoxy propion anhydride, γ-ethoxy butanoic anhydride, and the like.

본 발명의 화합물을 제조하는데 유용한 일반식(IV)으로 표시되는 적당한 산염화물의 예는 산무수물의 예에서 상술한 것과같은 동일한 산의 산 염화물이다.Examples of suitable acid chlorides represented by general formula (IV) useful for preparing the compounds of the present invention are acid chlorides of the same acid as described above in the examples of acid anhydrides.

본 발명의 화합물 제조방법을 다음 실시예에 따라 더욱 상술한다.The preparation method of the compound of the present invention is further described according to the following examples.

[실시예 1]Example 1

5-메틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체의 제조Preparation of 5-methyl-1,3,4-thiadiazol-2-yl isocyanate dimer

에틸아세테이트 100ml에 용해된 포스겐의 포화용액을 기계적 교반기가 장치된 유리반응용기에 넣는다. 에틸아세테이트 300ml에 용해된 5-메틸-2-아미노-1,3,4-티아디아졸의 슬러리 40g을 반응용기에 첨가하고 생성된 혼합물을 16시간 동안 교반하면 침전물이 생성된다. 반응혼합물을 질소가스로 세척하여 미반응 포스겐을 제거시키고 세척된 혼합물을 여과하여 침전물을 회수한 다음 침전물을 재결정하면 원하는 생성물 5-메틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.Saturated solution of phosgene dissolved in 100 ml of ethyl acetate is placed in a glass reaction vessel equipped with a mechanical stirrer. 40 g of a slurry of 5-methyl-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate is added to the reaction vessel, and the resulting mixture is stirred for 16 hours to form a precipitate. The reaction mixture was washed with nitrogen gas to remove unreacted phosgene, the washed mixture was filtered to recover the precipitate, and the precipitate was recrystallized to give the desired product 5-methyl-1,3,4-thiadiazol-2-yl isocyanate equivalent. Sieve is generated.

[실시예 2]Example 2

3-메틸아미노 프로피온 알데하이드의 디메틸 아체탈의 제조Preparation of Dimethyl Acetal of 3-Methylamino Propion Aldehyde

메틸아민 1.0몰, 트로모 프르피온 알데하이드의 디메틸 아세탈 0.5몰과 메타놀 100ml을 기계적 교반기, 온도계 및 환류냉각기가 설치된 유리반응기에 넣는다. 반응홉합물을 환류온도에서 4시간동안 교반하면서 가열한다. 이 시간 후 반응혼합물을 상온까지 냉각하고 NaOH20g을 첨가한다. 반응혼합물을 8시간 더 교반한다. 반응혼합물을 여과하고 여액을 감압하에서 증류하던 원하는 생성물 3-메틸아미노 프로피온 알데 하이드의 디메틸 아세탈이 생성된다.1.0 mole of methylamine, 0.5 mole of dimethyl acetal of tromoprion aldehyde and 100 ml of methanol are placed in a glass reactor equipped with a mechanical stirrer, thermometer and reflux cooler. The reaction mixture is heated with stirring at reflux for 4 hours. After this time the reaction mixture is cooled to room temperature and NaOH20g is added. The reaction mixture is further stirred for 8 hours. The reaction mixture is filtered and the filtrate is distilled under reduced pressure to give dimethyl acetal of the desired product 3-methylamino propion aldehyde.

[실시예 3]Example 3

3-1-메틸-3-(5-메틸-1,3,4-티아디아졸-2-일) 유레이도 프로피온 알데하이드의 디지틸 아세탈의 제조Preparation of Digityl Acetal of 3-1-methyl-3- (5-methyl-1,3,4-thiadiazol-2-yl) ureido propionaldehyde

5-메틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체 0.05몰, 3-메틸 아미노 프로피온 알데하이드의 디메틸 아세탈 0.1몰과 벤젠 60ml의 혼합물을 기계적 교반기와 환류냉각기가 장치된 유리반응기에 넣는다. 반응혼합물을 환류온도에는 15분간 가열한다. 이 시간후 혼합물은 감압하에서 벤젠을 제거하면 잔사로 고체 생성물이 생성된다. 이 잔사를 재결정하면 원하는 생성물 3-1-메틸-3-(5-메틸-1,3,4-티아디아졸-2-일)유레이도 프로피온 알데하이드의 디메틸 아세탈이 생성된다.A mixture of 0.05 mole of 5-methyl-1,3,4-thiadiazol-2-yl isocyanate dimer and 0.1 mole of dimethyl acetal of 3-methyl amino propionaldehyde and 60 ml of benzene was prepared in a glass reactor equipped with a mechanical stirrer and a reflux cooler. Put it in. The reaction mixture is heated to reflux for 15 minutes. After this time the mixture removes benzene under reduced pressure to give a solid product as a residue. Recrystallization of this residue yields dimethyl acetal of the desired product 3-1-methyl-3- (5-methyl-1,3,4-thiadiazol-2-yl) ureido propionaldehyde.

[실시예 4]Example 4

테드라하이드로-1-(5-메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온의 제조Preparation of Tetrahydro-1- (5-methyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-메틸-3-(5-메틸-1,3,4-티아디아졸-2-일)유레이도] 프로피온 알데하이드의 디메틸 아세탈 15g, 물 400ml과 염산 4ml을 기계적 교반기, 온도계와 환류냉각기가 장치된 유리반응기에 넣는다. 반응 혼합물을 환류온도에서 15분간 가열한다. 반응혼합물을 뜨겁게 여과하고 여액을 생각하면 침전물이 생성된다. 침전물은 여과에 의하여 회수하고 건조, 재결정하면 원하는 생성물 테드라 하이드로-1-(5-메틸-1,3,4-티아디아졸-2-일)--3-메틸-6-하이드록시-2-(1H)-피티미디온이 생성된다.3- [1-methyl-3- (5-methyl-1,3,4-thiadiazol-2-yl) ureido] 15 g of dimethyl acetal of propionaldehyde, 400 ml of water and 4 ml of hydrochloric acid were refluxed with a mechanical stirrer, thermometer and Place in a glass reactor equipped with a cooler. The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered hot and the filtrate is considered to form a precipitate. The precipitate is recovered by filtration, dried and recrystallized to give the desired product Tedra Hydro-1- (5-methyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-hydroxy-2 -(1H) -pithymidion is produced.

[실시예 5]Example 5

테트라하이드로-1-(5-메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세틸옥시-2(1H)-피리미딘온의 제조Preparation of Tetrahydro-1- (5-methyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetyloxy-2 (1H) -pyrimidinone

테트라하이드로-1-(5-메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘 온 0.1몰, 초산무수물 0.11몰, 토루엔 설포산 0.05g과 벤젠 100ml을 기계적교반기와 온도계가 장치된 유리반응용기에 넣는다. 반응혼합물을 증기요상에 2시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세틸옥시-2(1H)-피리미딘온이 생성된다.0.1 mol of tetrahydro-1- (5-methyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone, 0.11 mol of acetic anhydride, 0.05 g of toluene sulfoic acid and 100 ml of benzene are placed in a glass reaction vessel equipped with a mechanical stirrer and a thermometer. The reaction mixture is heated with steam stirring for 2 hours. After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue. Recrystallization of the residue gave the desired product tetra hydro-1- (5-methyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetyloxy-2 (1H) -pyrimidinone. do.

[실시예 6]Example 6

5-메톡시-1,3,4-티아디아졸-2-일 이소시아네이트 이량체의 제조Preparation of 5-methoxy-1,3,4-thiadiazol-2-yl isocyanate dimer

에틸아세테이트에 용해된 포스겐의 포화용액 100ml을 기계적 교반기가 장치된 유리반응기에 넣는다. 에틸아세테이트 300ml에 용해된 5-메톡시-2-아미노-1,3,4-티아디아졸의 슬러리 40g을 반응용기에 첨가하고 생성된 혼합물을 16시간동안 교반하면 침전물이 생성된다. 반응혼합물을 질소가스로 세척하면 미반응 포스겐이 제거된다. 세척된 혼합물을 여과하면 침전이 회수된다. 침전을 재결정하면 원하는 생성물 5-메톡시-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.100 ml of saturated solution of phosgene dissolved in ethyl acetate is placed in a glass reactor equipped with a mechanical stirrer. 40 g of a slurry of 5-methoxy-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate is added to the reaction vessel, and the resulting mixture is stirred for 16 hours to form a precipitate. Washing the reaction mixture with nitrogen gas removes unreacted phosgene. Filtration of the washed mixture recovers precipitation. Recrystallization of the precipitate yields the desired product 5-methoxy-1,3,4-thiadiazol-2-yl isocyanate dimer.

[실시예 7]Example 7

3-메틸 아미노 프로피온 알데하이드의 디메탈 아세탈의 제조Preparation of Dimetal Acetal of 3-Methyl Amino Propion Aldehyde

에틸아민 2.0몰, 3-프로모 프로피온 알데하이드의 디메틸 아세탈 1.0몰과 메타놀 100ml을 기계적 교반기, 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류도도에서 5시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하고 Na0H20g을 첨가한다. 반응혼합물을 12시간 더 교반한다. 반응혼합물을 여과하고 여액을 감압하에서 증류하면 원하는 생성물 3-에틸 아미노 프로피온 알데하이드의 디메탈 아세탈이 생성된다.2.0 mole of ethylamine, 1.0 mole of dimethyl acetal of 3-propo propionaldehyde and 100 ml of methanol are placed in a glass reaction vessel equipped with a mechanical stirrer, thermometer and reflux cooler. The reaction mixture is heated with stirring for 5 hours at reflux. After this time, the reaction mixture is cooled to room temperature and Na0H20g is added. The reaction mixture is further stirred for 12 hours. Filtration of the reaction mixture and distillation of the filtrate under reduced pressure yielded the dimetal acetal of the desired product 3-ethyl amino propion aldehyde.

[실시예 8]Example 8

3-[1-(에틸-3-(5-메톡신-1,3,4-티아디아졸-2-일)유레이도] 프로피온 알데하이드의 디메틸 아세탈의 제조Preparation of dimethyl acetal of 3- [1- (ethyl-3- (5-methoxin-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde

5-메톡시-1,3,4-티아디아졸-2-일 이소시아네이트 이량체 0.05몰, 3-에틸아미노 프로피온 알데하이드의 디메틸 아세탈 0.1몰과 벤젠 60ml을 기계적교반기와 환류냉각기가 장치된 유리반응기에 넣는다. 반응혼합물을 환류온도에서 15분간 가열한다.0.05 mol of 5-methoxy-1,3,4-thiadiazol-2-yl isocyanate dimer, 0.1 mol of dimethyl acetal of 3-ethylamino propionaldehyde and 60 ml of benzene were placed in a glass reactor equipped with a mechanical stirrer and a reflux cooler. Put it in. The reaction mixture is heated at reflux for 15 minutes.

이 시간후 혼합물을 감압하에서 벤젠을 제거하면 잔사로 고체 생성물이 생성된다. 잔사를 재결정하면 원하는 생성물 3-[1-(에틸-3-(5-메톡시-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디지틸 아세탈이 생성된다.After this time the mixture is removed from the benzene under reduced pressure to give a solid product as a residue. Recrystallization of the residue yields digityl acetal of the desired product 3- [1- (ethyl-3- (5-methoxy-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde.

[실시예 9]Example 9

테트라 하이드로-1-(5-메톡시-1,3,4-티아디아졸-2--일)-3-에틸-6-하이드록시-2(1H)-피리미딘온의 제조Preparation of Tetra Hydro-1- (5-methoxy-1,3,4-thiadiazol-2--yl) -3-ethyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-에틸-3-(5-메톡시-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈 15g 몰 400ml과 염산 4ml을 기계적 교반기, 온도계 및 환류냉각기가 장치된 유리 반응 용기에 넣는다.3- [1-ethyl-3- (5-methoxy-1,3,4-thiadiazol-2-yl) ureido] 400 ml of 15 g mol of dimethyl acetal of propionaldehyde and 4 ml of hydrochloric acid were added to a mechanical stirrer, thermometer and reflux. Place in a glass reaction vessel equipped with a cooler.

반응혼합물을 환류온도에서 15분간 가열한다. 반응혼합물을 뜨거울때 여과한 다음 여액을 냉각하면 침전물이 생성된다. 침전물을 여과에 의하여 회수하고 건조하면 제결정하면 원하는 생성물 테트라 하이드로 -1-(5-메톡시-1,3,4-티아디아졸-2-일)-3-에틸-6-하이드록시-2(1H)-피리미딘온이 생성된다.The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered when hot and the filtrate is cooled down to form a precipitate. The precipitate is recovered by filtration and dried to crystallize the desired product tetrahydro-1- (5-methoxy-1,3,4-thiadiazol-2-yl) -3-ethyl-6-hydroxy-2 (1H) -pyrimidinone is produced.

[실시예 10]Example 10

테트라 하이드로-1-(5-메톡시-1,3,4-티아디아졸-2일)-3-에틸-프로피오닐옥시-2(1H)-피리미딘온의 제조Preparation of Tetrahydro-1- (5-methoxy-1,3,4-thiadiazol-2yl) -3-ethyl-propionyloxy-2 (1H) -pyrimidinone

테트라하이드로-1-(5-메톡시-1,3,4-티아디아졸-2-일)-3-에틸-6-하이드록시-2(1H)-피리미딘온 0.1몰, 프로피온산 무수물 0.11몰, 토투엔 설포산 0.05g과 벤젠 100ml을 기계적 교반기와 온도계가 장치된 유리반응기에 넣는다. 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메톡시-1,3,4-티아디아졸-2-일)-3-에틸-6-프로피오닐옥시-2(1H)-피리미딘온이 생성된다.Tetrahydro-1- (5-methoxy-1,3,4-thiadiazol-2-yl) -3-ethyl-6-hydroxy-2 (1H) -pyrimidinone 0.1 mole, propionic anhydride 0.11 mole , 0.05 g of totoene sulfoic acid and 100 ml of benzene are placed in a glass reactor equipped with a mechanical stirrer and thermometer. After cooling the reaction mixture to room temperature and removing the solvent under reduced pressure, a residue is left. Recrystallization of the residue affords the desired product tetra hydro-1- (5-methoxy-1,3,4-thiadiazol-2-yl) -3-ethyl-6-propionyloxy-2 (1H) -pyrimidinone. Is generated.

[실시예 11]Example 11

5-메틸티오-1,3,4-티아디아졸-2-일 이소시아네이트 이량체의 제조Preparation of 5-methylthio-1,3,4-thiadiazol-2-yl isocyanate dimer

에틸 아세테이트 100ml에 용해된 포소겐의 포화용액을 기계적 교반기가 장치된 유리반응기에 넣는다.A saturated solution of posogen dissolved in 100 ml of ethyl acetate is placed in a glass reactor equipped with a mechanical stirrer.

에틸아세테이트 300ml에 용해된 5-메틸티오-2-아미노-1,3,4-티아디아졸의 슬러리 45g을 반응용기에 첨가하고 생성된 혼합물을 16시간 동안 교반하면 침전물이 생성된다. 반응혼합물을 질소가스로 세척하면 미반응 포소겐이 제거된다. 세척된 혼합물을 여과하면 침전이 회수된다. 침전물을 재결정하면 원하는 생성물 5-메틸티오-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.45 g of a slurry of 5-methylthio-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate was added to the reaction vessel, and the resulting mixture was stirred for 16 hours to form a precipitate. Washing the reaction mixture with nitrogen gas removes unreacted posogen. Filtration of the washed mixture recovers precipitation. Recrystallization of the precipitate yields the desired product 5-methylthio-1,3,4-thiadiazol-2-yl isocyanate dimer.

[실시예 12]Example 12

3-프로필 아미노 프로피온 알데하이드 디메틸 아세탈의 제조Preparation of 3-propyl amino propionaldehyde dimethyl acetal

프로필아민 2.0몰, 3-프로모프로피온 알데하이드의 디메틸 아세탈 1. 0몰과 메타놀 100ml을 기계적 교반기, 온도계 및 환류냉각기가 장치된 유리반응용기에 넣는다.2.0 moles of propylamine, dimethyl acetal 1.0 moles of 3-propomopropion aldehyde and 100 ml of methanol are placed in a glass reaction vessel equipped with a mechanical stirrer, thermometer and reflux cooler.

반응혼합물을 환류온도에서 3시간 동안 교반하면서 가열한다. 이 시간 후 반응혼합물을 상온까지 냉각 시키고 NaOH20g을 첨가한다. 반응혼합물을 여과하고 여액을 감압하에서 증류하면 원하는 생성물 3-프로필 아미노 프로피온 알데하이드의 디메틸 아세탈이 생성된다.The reaction mixture is heated with stirring at reflux for 3 hours. After this time, the reaction mixture is cooled to room temperature and NaOH20g is added. Filtration of the reaction mixture and distillation of the filtrate under reduced pressure yielded dimethyl acetal of the desired product 3-propyl amino propionaldehyde.

[실시예 13]Example 13

3-[1-프로필-3-(5-메틸티오-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈의 제조Preparation of dimethyl acetal of 3- [1-propyl-3- (5-methylthio-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde

5-메틸티오-1,3,4-티아디아졸-2-일 이소시아네이트 이량체 0.05몰, 3-프로필 아미노 프로피온 알데하이드 0.1몰과 벤젠 60ml의 혼합물을 기계적 교반기와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류온도에서 15분간 가열한다. 이 시간후 혼합물은 감압하에서 벤젠을 제거하면 잔사로서 고체 생성물이 생성된다. 잔사를 재결정하면 원하는 생성물 3-[1-프로필-3-(5-메틸티오-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈이 생성된다.A mixture of 0.05 mol of 5-methylthio-1,3,4-thiadiazol-2-yl isocyanate dimer, 0.1 mol of 3-propyl amino propionaldehyde and 60 ml of benzene was placed in a glass reaction vessel equipped with a mechanical stirrer and a reflux cooler. Put it in. The reaction mixture is heated at reflux for 15 minutes. After this time the mixture removes benzene under reduced pressure to give a solid product as a residue. Recrystallization of the residue gives the dimethyl acetal of the desired product 3- [1-propyl-3- (5-methylthio-1,3,4-thiadiazol-2-yl) eureido] propion aldehyde.

[실시예 14]Example 14

테트라 하이드로-1-(5-메틸티오-1,3,4-티아디아졸-2-일)-3-프로필-6-하이드록시-2(1H)- 피리미딘온의 제조Preparation of Tetrahydro-1- (5-methylthio-1,3,4-thiadiazol-2-yl) -3-propyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-프로필-3-(5-메틸티오-1,3,4-티아딘아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸아세탈 15g, 물 400ml과 염산 4ml을 기계적교반기, 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류온도에서 15분간 가열한다. 반응혼합물을 뜨거울때 여과하고 여액을 냉각하면 침전이 생성된다. 침전을 여과에 의하여 회수하고 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메틸티오-1,3,4-티아디아졸-2-일)-3-프로필-6-하이드록시-2( 1H )-피리미딘온이 생성된다.3- [1-propyl-3- (5-methylthio-1,3,4-thiadinazol-2-yl) ureido] 15 g of dimethylacetal of propionaldehyde, 400 ml of water and 4 ml of hydrochloric acid were mixed with a mechanical stirrer and a thermometer. Place in a glass reaction vessel equipped with a reflux condenser. The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered while hot and the filtrate is cooled to precipitate. The precipitate is recovered by filtration and recrystallized to give the desired product tetra hydro-1- (5-methylthio-1,3,4-thiadiazol-2-yl) -3-propyl-6-hydroxy-2 (1H) Pyrimidinone is produced.

[실시예 15]Example 15

테트라 하이드로-1-(5-메틸티오-1,3,4-티아디아졸-2-일)-3-프로필-6-부타노일옥시-2(1H)피리미딘온의 제조Preparation of tetra hydro-1- (5-methylthio-1,3,4-thiadiazol-2-yl) -3-propyl-6-butanoyloxy-2 (1H) pyrimidinone

테트라 하이드로-1-(5-메틸티오-1,3,4-티아디아졸-2-일)3-프로필-6-하이드록시-2(1H)-피리 미딘온 0.1몰, 부타노익무수물 0.11몰, 토루엔 설포산 0.05g과 벤젠 100ml을 기계적교반기와 온도계가 장치된 유리반응용기에 넣는다.Tetra hydro-1- (5-methylthio-1,3,4-thiadiazol-2-yl) 3-propyl-6-hydroxy-2 (1H) -pyrimidinone 0.1 mole, butanoic anhydride 0.11 mole , 0.05 g of toluene sulfoic acid and 100 ml of benzene are placed in a glass reaction vessel equipped with a mechanical stirrer and a thermometer.

반응혼합물을 증기욕상에서 2시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각시키고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메틸티오-1,3,4-티아디아졸-2-일)-3-프로필-6-부타노일록시-2(1H)-피리미딘온이 생성된다.The reaction mixture is heated with stirring for 2 h in a steam bath. After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue. Recrystallization of the residue affords the desired product tetra hydro-1- (5-methylthio-1,3,4-thiadiazol-2-yl) -3-propyl-6-butanoyloxy-2 (1H) -pyrimidinone. Is generated.

[실시예 16]Example 16

5-메틸설포닐-1,3,4-티아디아졸-2-일 이소시아네이트이량체의 제조Preparation of 5-methylsulfonyl-1,3,4-thiadiazol-2-yl isocyanate dimer

에틸 아세테이트 100ml에 용해된 포스겐의 포화용액을 기계적교반기가 장치된 유리반응 용기에 넣는다. 에틸 아세테이트 300ml에 용해된 5-메틸설포닐-2-아미노-1,3,4-티아디아졸의 슬러리 50g을 반응 용기에 첨가하고 생성된 혼합물을 16시간동안 교반하면 침전이 생성된다. 반응혼합물을 질소가스로 세척하면 미반응 포스겐이 제거된다.Saturated solution of phosgene dissolved in 100 ml of ethyl acetate is placed in a glass reaction vessel equipped with a mechanical stirrer. 50 g of a slurry of 5-methylsulfonyl-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate is added to the reaction vessel, and the resulting mixture is stirred for 16 hours to form a precipitate. Washing the reaction mixture with nitrogen gas removes unreacted phosgene.

세척된 혼합물을 여과하면 침전물이 회수된다. 침전물을 재결정하면 원하는 생성물 5-메틸설포닐-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.Filtration of the washed mixture recovers the precipitate. Recrystallization of the precipitate yields the desired product 5-methylsulfonyl-1,3,4-thiadiazol-2-yl isocyanate dimer.

[실시예 17]Example 17

3-아릴 아미노 프로피온 안데하이드의 디메틸 아세탈의 제조Preparation of Dimethyl Acetal of 3-aryl Amino Propion Andide

아릴 아민 1.0몰, 3-브로모 프로피온 알데하이드의 디메틸 아세탈 0.5몰과 메타논 100ml을 기계적교반기, 온도계와 환류냉각기가 장치된 유리반응기에 넣는다. 반응혼합물을 환류온도에서 8시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하하고 NaOH20g을 첨가한다.1.0 mole of aryl amine, 0.5 mole of dimethyl acetal of 3-bromo propionaldehyde and 100 ml of methanone are placed in a glass reactor equipped with a mechanical stirrer, thermometer and reflux cooler. The reaction mixture is heated with stirring for 8 hours at reflux temperature. After this time the reaction mixture is cooled to room temperature and 20 g of NaOH is added.

반응혼합물을 14시간 더 교반한다. 반응혼합물을 여과하고 여액을 감압하에서 증류하면 원하는 생성물 3-아틸아미노프로피온 알데하이드의 디메틸 아세탈이 생성된다.The reaction mixture is stirred for another 14 hours. Filtration of the reaction mixture and distillation of the filtrate under reduced pressure yielded dimethyl acetal of the desired product 3-acetylaminopropion aldehyde.

[실시예 18]Example 18

3-(1-아릴-3-(5-메틸설포닐-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈의 제조Preparation of dimethyl acetal of 3- (1-aryl-3- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde

5-메틸설포닐-1,3,4-티아디아졸-2-일 이소시아네이트 이량체 0.05롤, 3-아릴아미노 프로피온 알데하이드의 디메틸아세탈 0.1-몰과 벤젠 60ml을 기계적 교반기와 환류냉각기가 장치된 유리반응 용기에 넣는다. 반응혼합물을 15분간 가열한다. 이 시간후 혼합물은 감압하에서 벤젠을 제거하면 잔사로서 고체 생성물이 생성된다.0.05 roll of 5-methylsulfonyl-1,3,4-thiadiazol-2-yl isocyanate dimer, 0.1-mol of dimethylacetal and benzene of 3-arylaminopropion aldehyde and 60 ml of glass equipped with mechanical stirrer and reflux cooler Place in reaction vessel. The reaction mixture is heated for 15 minutes. After this time the mixture removes benzene under reduced pressure to give a solid product as a residue.

잔사를 재결정하면 원하는 생성물 3-[1-아릴-3-(5-메틸설포닐-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈이 생성된다.Recrystallization of the residue gives the dimethyl acetal of the desired product 3- [1-aryl-3- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde.

[실시예 19]Example 19

테트라 하이드로-1-(5-메틸설포닐-1,3,4-티아디아졸-2-일)-3-아릴-6-하이드록시-2(1H)-피라미딘온의 제조Preparation of Tetra Hydro-1- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) -3-aryl-6-hydroxy-2 (1H) -pyramimidone

3-1-메틸-3-(5-메틸설포닐-1,3,4-티아디아졸-2-일)유레이도 프로피온 알데하이드의 디메틸 아세탈 15g, 물 400ml과 염산 4ml을 기계적교반기, 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류 온도에서 15분간 가열한다. 반응혼합물을 뜨거울 때 여과하고 여액을 냉각하면 침전이 생성된다. 침전물을 여과에 의하여 회수하고 건조하고 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메틸 설포닐-1,3,4-티아디아졸-2-일)-3-아릴-6-하이드록시-2(1H)-피리미딘온이 생성된다.15 g of dimethyl acetal of 3-1-methyl-3- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) ureido propionaldehyde, 400 ml of water and 4 ml of hydrochloric acid were added to a mechanical stirrer, thermometer and reflux. Place in a glass reaction vessel equipped with a cooler. The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered when hot and the filtrate is cooled to precipitate. The precipitate is recovered by filtration, dried and recrystallized to give the desired product tetra hydro-1- (5-methyl sulfonyl-1,3,4-thiadiazol-2-yl) -3-aryl-6-hydroxy-2 (1H) -pyrimidinone is produced.

[실시예 20]Example 20

테트라 하이드로 1-(5-메틸설포닐-1,3,4-티아디아졸-2-일)-3-아릴-6-싸이크로 헥실 카보닐옥시-2(1H)-피리미딘온의 제조Preparation of Tetra Hydro 1- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) -3-aryl-6-cyclohexyl carbonyloxy-2 (1H) -pyrimidinone

테트라 하이드로-1-(5-메틸설포닐-1,3,4-티아디아졸-2-일)-3-아릴-6-하이드록시-2(1H)-피리미딘온 0.1몰, 싸이클로 헥산 카복실산 무수물 0.11몰, 토루엔설폰산 0.05g과 벤젠 100ml를 기계적 교반기와 온도계가 장치된 유리반응기에 넣는다. 반응혼합물을 증기욕상에서 2시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다.Tetrahydro-1- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) -3-aryl-6-hydroxy-2 (1H) -pyrimidinone 0.1 mole, cyclohexane carboxylic acid 0.11 mol of anhydride, 0.05 g of toluenesulfonic acid and 100 ml of benzene are placed in a glass reactor equipped with a mechanical stirrer and thermometer. The reaction mixture is heated with stirring for 2 h in a steam bath. After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue.

잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-메틸설포닐-1,3,4-티아디아졸-2-일)-3-아릴-6-싸이클로 헥실 카보닐옥시-2(IH)-피리미딘온이 생성된다.Recrystallization of the residue affords the desired product tetra hydro-1- (5-methylsulfonyl-1,3,4-thiadiazol-2-yl) -3-aryl-6-cyclohexyl carbonyloxy-2 (IH)- Pyrimidinone is produced.

[실시예 21]Example 21

5-싸이크로프로필-1,3,4-티아디아졸-2-일 이소시아네이트 이량체의 제조Preparation of 5-cyclopropyl-1,3,4-thiadiazol-2-yl isocyanate dimer

에틸아세테이트 100ml에 용해된 포스겐의 포화용액을 기계적 교반기가 장치된 유리반응 용기에 넣는다. 에틸 아세테이트 300ml에 용해된 5-싸이크로프로필-2-아미노-1,3,4-티아디아졸의 슬러리 50g을 반응용기에 첨가하고 생성된 혼합물을 16시간동안 교반하면 침전물이 생성된다.Saturated solution of phosgene dissolved in 100 ml of ethyl acetate is placed in a glass reaction vessel equipped with a mechanical stirrer. 50 g of a slurry of 5-cyclopropyl-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate is added to the reaction vessel, and the resulting mixture is stirred for 16 hours to form a precipitate.

반응혼합물을 질소가스로 세척하면 미반응 포스겐이 제거된다. 세척된 혼합물을 여과하던 침전물이 회수된다. 침전물을 재결정하던 원하는 생성물 5-싸이크로프로필-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.Washing the reaction mixture with nitrogen gas removes unreacted phosgene. The precipitate which filtered the washed mixture is recovered. The desired product 5-cyclopropyl-1,3,4-thiadiazol-2-yl isocyanate dimer is produced which recrystallizes the precipitate.

[실시예 22]Example 22

3-프로파길 아미노 프로피온 알데하이드의 디메틸 아세탈의 제법.Preparation of dimethyl acetal of 3-propargyl amino propion aldehyde.

프로파길 아민 2.0몰, 3-브로모 프로피온 알데하이드의 디메틸 아세탈 1.0몰과 메타놀 100ml을 기계적 교반기, 온도계와 환류냉각기가 장치된 유리반응 용기에 넣는다.2.0 moles of propargyl amine, 1.0 mole of dimethyl acetal of 3-bromo propion aldehyde and 100 ml of methanol are placed in a glass reaction vessel equipped with a mechanical stirrer, thermometer and reflux cooler.

반응혼합물을 환류온도에서 6시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하고 NaOH20g을 첨가한다. 반응혼합물을 18시간 더 교반한다. 반응혼합물을 여과하고 여액을 감압하에서 증류하면 원하는 생성물 3-프로파길 아미노 프로피온 알데하이드의 디메틸 아세탈이 생성된다.The reaction mixture is heated with stirring at reflux for 6 hours. After this time the reaction mixture is cooled to room temperature and NaOH20g is added. The reaction mixture is further stirred for 18 hours. Filtration of the reaction mixture and distillation of the filtrate under reduced pressure yielded dimethyl acetal of the desired product 3-propargyl amino propion aldehyde.

[실시예 23]Example 23

3-(1-프로파길-3-(5-싸이크로 프로필-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈의 제조Preparation of dimethyl acetal of 3- (1-propargyl-3- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde

5-싸이크로 프로필-1,3,4-티아디아졸-2-일 이소시아 네이트 이량체 0.05몰, 3-프로파길-아미노 프로피온 알데하이드의 디메틸 아세탈 0.1몰과 벤젠 60ml의 혼합물을 기계적교반기와 환류 냉각기가 장치된 유리반응기에 넣는다.A mixture of 0.05 mol of 5-cyclopropyl-1,3,4-thiadiazol-2-yl isocyanate dimer, 0.1 mol of dimethyl acetal of 3-propargyl-amino propionaldehyde and 60 ml of benzene was refluxed with a mechanical stirrer. Place in a glass reactor equipped with a cooler.

반응혼합물을 환류온도에서 15분간 가열한다. 이 시간후 혼합물을 감압하에서 벤젠을 제거하면 잔사로서 고체생성물이 생성된다. 잔사를 재결정하면 원하는 생성물 3-[1-프로파길-3-(5-싸이크로 프로필-1,3,4-티아디아졸-2-일)유레이도 프로피온 알데하이드의 디메틸 아세탈이 생성된다.The reaction mixture is heated at reflux for 15 minutes. After this time the mixture is removed from the benzene under reduced pressure to give a solid product as a residue. Recrystallization of the residue gives the dimethyl acetal of the desired product 3- [1-propargyl-3- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) ureido propionaldehyde.

[실시예 24]Example 24

테트라 하이드로-1-(5-싸이크로프로필-1,3,4-티아디아졸-2-일)-3-프로파길-6-하이드록시-2(1H)-피리미딘온의 제조Preparation of Tetra Hydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) -3-propargyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-프로파길-3-(5-싸이크로프로필-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈 15g, 물 400ml과 염산 4ml을 기계적교반기, 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류온도에서 15분간 가열한다. 반응혼합물을 뜨거울 때 여과하고 여액을 냉각하면 침전물이 생성된다. 침전물을 여과에 의하여 회수하고 건조하고 재결정하면 원하는 생성물 테트라 하이드로-1-(5-싸이크로프로필-1,3,4-티아디아졸-2-일)-3-프로파길-6-하이드록시-2(1H)-피리미딘온이 생성된다.3- [1-propargyl-3- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) ureido] 15 g of dimethyl acetal of propionaldehyde, 400 ml of water and 4 ml of hydrochloric acid were added to a mechanical stirrer, Place in a glass reaction vessel equipped with a thermometer and reflux condenser. The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered when hot and the filtrate is cooled to form a precipitate. The precipitate is recovered by filtration, dried and recrystallized to give the desired product tetra hydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) -3-propargyl-6-hydroxy- 2 (1H) -pyrimidinone is produced.

[실시예 25]Example 25

테트라 하이드로-1-(5-싸이크로프로필-1,3,4-티아디아졸-2-일)-3-프로파길-6-벤조일옥시-2(1H)-피리미온의 제조Preparation of Tetrahydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) -3-propargyl-6-benzoyloxy-2 (1H) -pyrimion

테트라 하이드로-1-(5-싸이크로프로필-1,3,4-티아디아졸-2-일)-3-프로파길-6-하이드록시-2(1H)-피리미딘온 0.1몰, 벤조의산 무수물 0.11몰, 토루엔 설포산 0.05g과 벤젠 100ml을 기계적 교반기와 온도계가 장치된 유리반응 용기에 넣는다. 반응혼합물을 증기욕상에서 2시간동안 교반하면서 가열한다. 이 시간후 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-싸이크로 프로필-1,3,4-티아디아졸-2-일)-3-프로파길-6-벤조익옥시-2(1H)-피리미딘온이 생성된다.Tetrahydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) -3-propargyl-6-hydroxy-2 (1H) -pyrimidinone 0.1 mole, of benzo 0.11 mol of acid anhydride, 0.05 g of toluene sulfoic acid and 100 ml of benzene are placed in a glass reaction vessel equipped with a mechanical stirrer and thermometer. The reaction mixture is heated with stirring for 2 h in a steam bath. After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue. Recrystallization of the residue affords the desired product tetra hydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl) -3-propargyl-6-benzoicoxy-2 (1H) -pyri. Midinone is produced.

[실시예 26]Example 26

5-트리플로메틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체의 제조Preparation of 5-triflomethyl-1,3,4-thiadiazol-2-yl isocyanate dimer

아세테이트 100ml에 용해된 포스겐의 포화용액을 기계적교반기가 장치된 유리반응 용기에 넣는다. 에틸 아세테이트 300ml에 용해된 5-트리플로로메틸-2-아미노-1,3,4-티아디아졸의 슬러리 45g을 반응용기에 첨가하고 생성된 혼합물을 16시간 교반하면 침전물이 생성된다. 반응혼합물을 질소가스로 제거하면 미반응포스겐이 제거된다.Saturated solution of phosgene dissolved in 100 ml of acetate is placed in a glass reaction vessel equipped with a mechanical stirrer. 45 g of a slurry of 5-trifluoromethyl-2-amino-1,3,4-thiadiazole dissolved in 300 ml of ethyl acetate was added to the reaction vessel, and the resulting mixture was stirred for 16 hours to form a precipitate. Removing the reaction mixture with nitrogen gas removes unreacted posgen.

세척된 혼합물을 여과하면 백색고체 48g이 회수된다. 이 고체를 디메틸 포름 아마이드로 부터 재결정하면 원하는 생성물 5-트리플로 메틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.Filtration of the washed mixture recovered 48 g of white solid. Recrystallization of this solid from dimethyl formamide yields the desired product 5-triflo methyl-1,3,4-thiadiazol-2-yl isocyanate dimer.

[실시예 27]Example 27

3-[1-메틸-3-(5-트리플로로메틸-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈의 제조Preparation of dimethyl acetal of 3- [1-methyl-3- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde

5-트리플로로메틸-1,3,4-티아디아졸-2-일 이소시아네이트이량체 9.5g, 3-메틸-아미노 프로피온 알데하이드의 디메틸 아세탈 5.8g과 벤젠 60ml의 혼합물을 기계적교반기와 환류냉각기가 장치된 유리반응 용기에 넣는다.A mixture of 9.5 g of 5-trifluoromethyl-1,3,4-thiadiazol-2-yl isocyanate dimer and 5.8 g of dimethyl acetal of 3-methyl-amino propionaldehyde and 60 ml of benzene was equipped with a mechanical stirrer and a reflux cooler. Into a glass reaction vessel.

반응혼합물을 환류온도에서 15분간 가열한다. 이 시간후 혼합물을 감압하에서 벤젠을 제거하면 잔사로서 고체생성물이 생성된다. 이 생성물을 재결정하면 원하는 생성물 3-[1-메틸-3-3-(5-트리플로로메틸-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈이 생성된다.The reaction mixture is heated at reflux for 15 minutes. After this time the mixture is removed from the benzene under reduced pressure to give a solid product as a residue. Recrystallization of this product yields the dimethyl acetal of the desired product 3- [1-methyl-3-3- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde. do.

[실시예 28]Example 28

테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온의 제조Preparation of tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-메틸-3-(5-트리플로로메틸-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈 15g, 물 400ml과 염산 4ml을 기계적 교반기, 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 환류온도에서 15분간 가열한다. 반응혼합물을 뜨거울때 여과하고 여액을 냉각하면 침전물이 생성된다. 침전물을 여과에 의하여 회수하고 건조하고 재결정하면 원하는 생성물 테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3--메틸-6-하이드록시-2(1H)-피리미딘온이 생성된다.15 g of dimethyl acetal of 3- [1-methyl-3- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) ureido] propionaldehyde, 400 ml of water and 4 ml of hydrochloric acid were added to a mechanical stirrer, Place in a glass reaction vessel equipped with a thermometer and reflux condenser. The reaction mixture is heated at reflux for 15 minutes. The reaction mixture is filtered when hot and the filtrate is cooled to form a precipitate. The precipitate is recovered by filtration, dried and recrystallized to give the desired product tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3--methyl-6-hydroxy -2 (1H) -pyrimidinone is produced.

[실시예 29]Example 29

테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세탈옥시-2(1H)-피리미딘온의 제조Preparation of tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetaloxy-2 (1H) -pyrimidinone

테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온 0.1몰, 초산무수물 0.11몰, 토루엔 설포산 0.05g과 벤젠 100ml을 기계적 교반기와 온도계가 장치된 유리반응 용기에 넣는다. 반응혼합물을 증기욕상에서 2시간동안 교반하면서 가열한다. 이 시간 후 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세틸옥시-2(1H)-피리미딘온이 생성된다.Tetrahydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone 0.1 mol, acetic anhydride 0.11 mol, 0.05 g of toluene sulfoic acid and 100 ml of benzene are placed in a glass reaction vessel equipped with a mechanical stirrer and thermometer. The reaction mixture is heated with stirring for 2 h in a steam bath. After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue. Recrystallization of the residue affords the desired product tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetyloxy-2 (1H) -pyrimi Dion is produced.

[실시예 30]Example 30

5-

Figure kpo00021
-부틸-1,3,4-티아디아졸-2-일 이소시아네이드 이량체의 제조5-
Figure kpo00021
Preparation of -butyl-1,3,4-thiadiazol-2-yl isocyanide dimer

에틸 아세테이트 100ml에 용해된 포스겐의 포화용액을 기계적 교반기가 장치된 유리반응 용기에 넣는다. 에틸아세테이트 300ml에 용해된 5-

Figure kpo00022
-부틸-2-아미노-1,3,4-티아디아졸의 슬러리 10g을 반응용기에 첨가하고 생성된 혼합물을 16시간동안 교반하면 침전물이 생성된다. 반응혼합물을 질소가스로 세척하면 미반응 포스겐이 제거된다.A saturated solution of phosgene dissolved in 100 ml of ethyl acetate is placed in a glass reaction vessel equipped with a mechanical stirrer. 5- dissolved in 300 ml of ethyl acetate
Figure kpo00022
10 g of a slurry of -butyl-2-amino-1,3,4-thiadiazole is added to the reaction vessel and the resulting mixture is stirred for 16 hours to form a precipitate. Washing the reaction mixture with nitrogen gas removes unreacted phosgene.

세척된 혼합물을 여과하면 융점 261-263℃를 갖는 고체로서 원하는 생성물 5-

Figure kpo00023
-부틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체가 생성된다.The washed mixture was filtered to give the desired product as a solid having a melting point of 261-263 ° C. 5-
Figure kpo00023
-Butyl-1,3,4-thiadiazol-2-yl isocyanate dimer is produced.

[실시예 31]Example 31

3-1-메틸-3-(5-

Figure kpo00024
-부틸-1,3,4-티아디아졸-2-일 유레이도 프로피온 알데하이드의 디메틸 아세탈의 제조3-1-methyl-3- (5-
Figure kpo00024
Preparation of Dimethyl Acetal of -Butyl-1,3,4-thiadiazol-2-yl ureido propionaldehyde

5-

Figure kpo00025
-부틸-1,3,4-티아디아졸-2-일 이소시아네이트 이량체 6g, 3-메틸아미노 프로피온 알데하이드의 디메틸 아세탈 4.0g과 벤젠 50ml의 혼합물을 기계적 교반기와 환류냉각기가 장치된 유리반응 후라스크에 넣는다. 반응혼합물을 환류온도에서 5분간 교반하면서 가열한다. 이 시간후 반응혼합물을 벤젠을 제거하면 잔사가 생성된다. 잔사를 재결정하면 원하는 생성물 3-[1-메틸-3-(5-부틸-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈이 생성된다.5-
Figure kpo00025
A mixture of 6 g of -butyl-1,3,4-thiadiazol-2-yl isocyanate dimer, 4.0 g of dimethyl acetal of 3-methylamino propionaldehyde and 50 ml of benzene was prepared by a glass reaction flask equipped with a mechanical stirrer and a reflux condenser. Put it in. The reaction mixture is heated with stirring at reflux for 5 minutes. After this time, benzene is removed from the reaction mixture to form a residue. Recrystallization of the residue gives the dimethyl acetal of the desired product 3- [1-methyl-3- (5-butyl-1,3,4-thiadiazol-2-yl) ureido] propion aldehyde.

[실시예 32]Example 32

테트라 하이드로-1-(5-

Figure kpo00026
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온의 제조Tetra hydro-1- (5-
Figure kpo00026
Preparation of -Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone

3-[1-메틸-3-(5-부틸-1,3,4-티아디아졸-2-일) 유레이도] 프로피온 알데하이드의 디메틸 아세탈 16g, 농염산 10ml와 물 500ml을 기계적 교반기와 온도계와 환류냉각기가 장치된 유리반응용기에 넣는다. 반응혼합물을 뜨거울때 여과하고 여액을 냉각하면 침전물이 생성된다.3- [1-methyl-3- (5-butyl-1,3,4-thiadiazol-2-yl) ureido] 16 g of dimethyl acetal of propionaldehyde, 10 ml of concentrated hydrochloric acid and 500 ml of water were prepared with a mechanical stirrer and thermometer. Place in a glass reaction vessel equipped with a reflux condenser. The reaction mixture is filtered when hot and the filtrate is cooled to form a precipitate.

침전물을 여과에 의하여 회수하고 건조하고 재결정하면 원하는 생성물 테트라 하이드로-1-(5-

Figure kpo00027
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온이 생성된다.The precipitate is recovered by filtration, dried and recrystallized to give the desired product tetrahydro-1- (5-
Figure kpo00027
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone is produced.

[실시예 33]Example 33

테트라 하이드로-1-(5-

Figure kpo00028
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세탈옥시-2(1H)-피리미딘온의 제조 테트라 하이드로-1-(5-
Figure kpo00029
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온 0.1몰, 초산무수물 0.11몰, 토루엔 설포산 0.05g과 벤젠 100ml을 기계적 교반기와 온도계가 장치된 유리반응 용기에 넣는다. 반응혼합물을 증기욕상에서 2시간동안 교반하면서 가열한다.Tetra hydro-1- (5-
Figure kpo00028
Preparation of -Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetaloxy-2 (1H) -pyrimidinone Tetrahydro-1- (5-
Figure kpo00029
0.1 mol of -butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone, 0.11 mol of acetic anhydride, and 0.05 g of toluene sulfoic acid; 100 ml of benzene is placed in a glass reaction vessel equipped with a mechanical stirrer and thermometer. The reaction mixture is heated with stirring for 2 h in a steam bath.

이 시간후 반응혼합물을 상온까지 냉각하고 감압하에서 용매를 제거하면 잔사가 남는다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-

Figure kpo00030
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아세틸옥시-2(1H)-피리미딘온이 생성된다.After this time, the reaction mixture is cooled to room temperature and the solvent is removed under reduced pressure, leaving a residue. Recrystallization of the residue affords the desired product tetrahydro-1- (5-
Figure kpo00030
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-acetyloxy-2 (1H) -pyrimidinone is produced.

[실시예 34]Example 34

테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-벤조일옥시-2(1H)-피리미딘온의 제조Preparation of tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-benzoyloxy-2 (1H) -pyrimidinone

테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-하이드록시-2(1H)-피리미딘온 0.05몰, 트리에틸아민 0.06몰과 벤젠 50ml을 기계적 교반기, 온도계와 환류냉각기가 장치된 유리 반응용기에 넣는다.Tetrahydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone 0.05 mole, triethyl 0.06 moles of amine and 50 ml of benzene are placed in a glass reaction vessel equipped with a mechanical stirrer, thermometer and reflux cooler.

벤조일 크로라이드 0.05몰은 교반하면서 첨가한다. 첨가가 완료된후 반응혼합물을 환류온도에서 30분동안 계속해서 교반하면서 가열한다. 이 시간후 반응혼합물을 여과하고 여액을 감압하에서 용매를 제거하면 고체 잔사가 생성된다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-벤조일옥시-2(H)-피리미딘온이 생성된다.0.05 mole of benzoyl chloride is added with stirring. After the addition is complete, the reaction mixture is heated with continuous stirring at reflux for 30 minutes. After this time, the reaction mixture is filtered and the filtrate is removed under reduced pressure to give a solid residue. Recrystallization of the residue affords the desired product tetra hydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-benzoyloxy-2 (H) -pyrimi Dion is produced.

[실시예 35]Example 35

테트라 하이드로-1-(5-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-벤조일옥시-2(1H)-피리미딘온의 제조Preparation of tetra hydro-1- (5-butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-benzoyloxy-2 (1H) -pyrimidinone

테트라 하이드로-1-(5-

Figure kpo00031
-부틸-1,3,4-티아디아졸-2--일)-3-메틸-6-하이드록시-2(1H)-피리미딘온 0.05몰, 트리에틸 아민 0.06몰과 벤젠 50ml을 기계적교반기, 온도계와 환류냉각기가 장치된 유리 반응 용기에 넣는다.Tetra hydro-1- (5-
Figure kpo00031
0.05 mol of -butyl-1,3,4-thiadiazol-2--yl) -3-methyl-6-hydroxy-2 (1H) -pyrimidinone, 0.06 mol of triethylamine and 50 ml of benzene , Into a glass reaction vessel equipped with a thermometer and reflux condenser.

벤조일 크로라이드 0.05몰을 교반하면서 적가한다. 첨가가 완료된 후 반응혼합물을 환류온도에서 30분간 교반을 계속하면서 가열한다. 이 시간후 반응혼합물을 여과하고 여액을 감압하에서 용매를 제거하면 고체잔사가 생성된다. 잔사를 재결정하면 원하는 생성물 테트라 하이드로-1-(5-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-벤조일옥시-2(1H)-피리미딘온이 생성된다. 전기실시예의 제조방법에 의하여 제조된 본 발명의 범위내의 부가적 화합물로는 테트라 하이드로-1-(5-에틸-1,3,4-티아디아졸-2-일)-3-메틸-6-아크릴로일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-프로필-1,3,4-티아디아졸-2-일)-3-부틸-6-But-3-에노일옥시-2(1H)--피리미딘온, 테트라 하이드로-1-(5-부틸-1,3,4-티아디아졸-2-일)-3-펜틸-6-Pent-3-에노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-펜틸-1,3,4-티아디아졸-2-일(-3-헥실-6-hex-4-에노일옥시-2(1H)-피리미딘온, 테트라 하이드로-1-(5-헥실-1,3,4-티아디아졸-2-일)-3-pent-3-에틸-6-펜타노일옥시-2(1H)-피리미딘온, 테트라 하이드로-1-(5-싸이크로프로필-1,3,4-티아디아졸-2-일-3-hex-4-에닐-6-헥사노일옥시-2(1H)-피리미딘온, 테트라 하이드로-1-(5-싸이크로부틸-1,3,4-티아디아졸-2-일)-3-브로모메틸-6-부타노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-싸이크로펜틸-1,3,4-티아디아졸-2-일)-3-트리크로로메틸-6-크로로 아세탈옥시-2(1H)-피리미딘온, 테트라 하이드로-1-(5-싸이크로헥실-1,3,4-티아디아졸-2-일)-3-β-크로로헥실-6-브로모아세틸옥시-2(1H)-피리미딘온 테트라하이드로-1-(5-싸이크로헵틸-1,3,4-티아디아졸-2-일)-3-β-브로모에틸-6-β-크로로부타노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-아릴-1,3,4-티아디아졸-2-일)-3-(1,1-디에틸프롭-2-이닐)-6-싸이크로프로필-카보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-but-3-에닐-1,3,4-티아디아졸-2-일)-3-(1,1-디프로필롭롬-2-이닐)-6-싸이크로부틸-카보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-4-에닐-1,3,4-티아디아졸-2-일)-3-메틸-싸이크로펜틸 차보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-pent-4-에닐-1,3,4-티아디아졸-2-일)-3-메틸-6-싸이크로헥실-카보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-hex-4-에닐-1,3,4-티아디아졸-2-일)-3-메틸--6-싸이크로 헥실카보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-크로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-싸이크로헵틸-카보닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-브로모메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-메틸틱오벤조일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-트리크로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-에틸티오벤조일옥시)-2(1H)-피리미디온, 테트라하이드로-1-(5-β-크로로에틸-1,3,4-티아디아졸-2-일)-3-메틸-6-(3-프로필티오벤조일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-β-브로모에틸-1,3,4-티아디아졸-2-일)-3-메틸-6-(3-헥실 티오벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-W-크로로헤실-1,3,4-티아디아졸-2-일)-3-메틸-6-(3,4,5-트리크로로벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-에톡시1,3,4-티아다아졸-2-일)-3-메틸-6-(3-에틸 벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-프로폭시-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-프로필벤조일옥시-2(1H)-피리미딘온, 테트라히이드로-1-(5-부톡시-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-부틸벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-헥실옥시-1,3,4-피아디아졸-2-일)-3-메틸-3-(4-헥실벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-에틸티오-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-브로모벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1--(5-프로필피오-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-아이오도벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-헥실티오-1,3,4-티아디아졸-2-일)-3-메틸-6-(2-플로로벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-에틸설포닐-1,3,4-티아디아졸-2-일)-3-메틸-6-(2-에톡시벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-프로필설포닐-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-프로폭시벤조일옥시)-2(1H)-피리미딘온, 테트라 하이드로-1-(5-부틸설포닐-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-헥실옥시벤조일옥시)-2(1H)-피리미딘온, 테트라 하이드로-1-(5-헥실설포닐-1,3,4-티아디아졸-2-일)-3-메틸-6-(3-크로로메틸 벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-에틸설피닐-1,3,4-티아디아졸-2-메틸-6-(4-트리플로로 메틸벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-프로필 설피닐-1,3,4-티아디아졸-2-일)-3-메틸-6-(4-β-브로모에틸 벤조일옥시)-2(1H)-피리미딘온, 테트라하이드로-1-(5-헥실설피닐-1,3,4-티아디아졸-2-일)-3-메틸-6-아세탈옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-브로모아세틸옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-β-크로로프로파노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-트리플로로메틸-1,3,4-티아디아졸-2-일)-3-메틸-6-β-브로모펜타노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-트리플로로토메틸-1,3,4-티아다아졸-2-일)-3-메틸-6-W-크로로헥사노일옥시-2(1H)-피리미딘은, 테트라하이드로-1-(5-

Figure kpo00032
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-but-3-에노일옥시-2(1H)-피리미딘올, 테트라하이드로-1-(5-
Figure kpo00033
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-pent-4-에노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-
Figure kpo00034
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-hex-4-에노일옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-
Figure kpo00035
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-but-3-이닐옥시-2(1H)-피리미딘온, 테트라하이드로-1-(5-
Figure kpo00036
-부틸-1,3,4-티아디아졸-2-일)-3-메틸-6-hex-4-이노일옥시-2(1H)-피리미딘온 등이 있다.0.05 mole of benzoyl chloride is added dropwise with stirring. After the addition is complete, the reaction mixture is heated with stirring for 30 minutes at reflux temperature. After this time, the reaction mixture is filtered and the filtrate is removed under reduced pressure to form a solid residue. Recrystallization of the residue gave the desired product tetra hydro-1- (5-butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-benzoyloxy-2 (1H) -pyrimidinone. do. Additional compounds within the scope of the present invention prepared by the preparation method of the above examples are tetra hydro-1- (5-ethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6- Acryloyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-propyl-1,3,4-thiadiazol-2-yl) -3-butyl-6-But-3-eno Iloxy-2 (1H)-pyrimidinone, tetra hydro-1- (5-butyl-1,3,4-thiadiazol-2-yl) -3-pentyl-6-Pent-3-enoyljade Ci-2 (1H) -pyrimidinone, tetrahydro-1- (5-pentyl-1,3,4-thiadiazol-2-yl (-3-hexyl-6-hex-4-enoyloxy- 2 (1H) -pyrimidinone, tetra hydro-1- (5-hexyl-1,3,4-thiadiazol-2-yl) -3-pent-3-ethyl-6-pentanoyloxy-2 ( 1H) -pyrimidinone, tetra hydro-1- (5-cyclopropyl-1,3,4-thiadiazol-2-yl-3-hex-4-enyl-6-hexanoyloxy-2 (1H) ) -Pyrimidinone, tetra hydro-1- (5-cyclobutyl-1,3,4-thiadiazol-2-yl) -3-bromomethyl-6-butanoyloxy-2 (1H)- Pyrimidinone, tetra Idro-1- (5-cyclopentyl-1,3,4-thiadiazol-2-yl) -3-trichloromethyl-6-chloro acetaloxy-2 (1H) -pyrimidinone, tetra Hydro-1- (5-cyclohexyl-1,3,4-thiadiazol-2-yl) -3-β-chlorohexyl-6-bromoacetyloxy-2 (1H) -pyrimidinone tetra Hydro-1- (5-cycloheptyl-1,3,4-thiadiazol-2-yl) -3-β-bromoethyl-6-β-crorobutanoyloxy-2 (1H) -pyri Midinone, tetrahydro-1- (5-aryl-1,3,4-thiadiazol-2-yl) -3- (1,1-diethylprop-2-ynyl) -6-cyclopropyl- Carbonyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-but-3-enyl-1,3,4-thiadiazol-2-yl) -3- (1,1-di Propylbrom-2-ynyl) -6-cyclobutyl-carbonyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-4-enyl-1,3,4-thiadiazole-2 -Yl) -3-methyl-cyclopentyl carbonyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-pent-4-enyl-1,3,4-thiadiazole-2- Yl) -3-methyl-6-cyclohexyl-carbo Nyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-hex-4-enyl-1,3,4-thiadiazol-2-yl) -3-methyl--6-cyclo Hexylcarbonyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-chloromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-cycloheptyl -Carbonyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-bromomethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4- Methyl thibenzoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-trichloromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4 -Ethylthiobenzoyloxy) -2 (1H) -pyrimidione, tetrahydro-1- (5-β-chloroethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6 -(3-propylthiobenzoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-β-bromoethyl-1,3,4-thiadiazol-2-yl) -3-methyl -6- (3-hexyl thiobenzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-W-chlorohesyl-1,3,4-thiadiazol-2-yl)- 3-methyl-6- (3,4,5-trichlorobenzoyljade ) -2 (1H) -pyrimidinone, tetrahydro-1- (5-ethoxy1,3,4-thiadaazol-2-yl) -3-methyl-6- (3-ethyl benzoyloxy)- 2 (1H) -pyrimidinone, tetrahydro-1- (5-propoxy-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4-propylbenzoyloxy-2 ( 1H) -pyrimidinone, tetrahydro-1- (5-butoxy-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4-butylbenzoyloxy) -2 ( 1H) -pyrimidinone, tetrahydro-1- (5-hexyloxy-1,3,4-piadiazol-2-yl) -3-methyl-3- (4-hexylbenzoyloxy) -2 ( 1H) -pyrimidinone, tetrahydro-1- (5-ethylthio-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4-bromobenzoyloxy) -2 ( 1H) -pyrimidinone, tetrahydro-1-(5-propylpio-1,3,4-thiadiazol-2-yl) -3-methyl-6- (4-iodobenzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-hexylthio-1,3,4-thiadiazol-2-yl) -3-methyl-6- (2-fluorobenzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-ethylsulfonyl-1,3,4-thiadi Zol-2-yl) -3-methyl-6- (2-ethoxybenzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-propylsulfonyl-1,3,4-thia Diazol-2-yl) -3-methyl-6- (4-propoxybenzoyloxy) -2 (1H) -pyrimidinone, tetra hydro-1- (5-butylsulfonyl-1,3,4- Thiadiazol-2-yl) -3-methyl-6- (4-hexyloxybenzoyloxy) -2 (1H) -pyrimidinone, tetra hydro-1- (5-hexylsulfonyl-1,3,4 -Thiadiazol-2-yl) -3-methyl-6- (3-chloromethyl benzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-ethylsulfinyl-1,3 , 4-thiadiazole-2-methyl-6- (4-trifluoro methylbenzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-propyl sulfinyl-1,3,4 -Thiadiazol-2-yl) -3-methyl-6- (4-β-bromoethyl benzoyloxy) -2 (1H) -pyrimidinone, tetrahydro-1- (5-hexylsulfinyl-1 , 3,4-thiadiazol-2-yl) -3-methyl-6-acetaloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-trifluoromethyl-1,3,4 -Thiadiazol-2-yl) -3-methyl-6- Bromoacetyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-β- Chloropropanoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl) -3-methyl-6- β-bromopentanoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-trifluorotomethyl-1,3,4-thiadaazol-2-yl) -3-methyl-6 -W-chlorohexanoyloxy-2 (1H) -pyrimidine is tetrahydro-1- (5-
Figure kpo00032
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-but-3-enoyloxy-2 (1H) -pyrimidinol, tetrahydro-1- (5-
Figure kpo00033
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-pent-4-enoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-
Figure kpo00034
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hex-4-enoyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-
Figure kpo00035
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-but-3-ynyloxy-2 (1H) -pyrimidinone, tetrahydro-1- (5-
Figure kpo00036
-Butyl-1,3,4-thiadiazol-2-yl) -3-methyl-6-hex-4-inoyloxy-2 (1H) -pyrimidinone and the like.

본 발명의 제조제 화합물로서 실질적으로 사용함은 일반적으로 불활담체와 그와같은 화합물의 제조활성 용량으로 구성된 제조제조성물로 제조된다. 이러한 제조제조성물을 제제로 하여 원하는 양만큼 잡초번식장소에 적용할 수 있도록 한다. 이들 조성물은 분제, 과립제 또는 습윤분말과 같은 고체로 하거나 용액, 에어로졸 또는 유화될 수 있는 농축물과 같은 액체로 할 수 있다. 예를들면 문제는 활성물질을 탈크, 점토실리카, 프로필라이드 등과 같은 고체 불활성 담체와 혼합 교반하여 제조할 수 있고 과립제는 화합물을 통상 적당한 용매에 용해시켜 보통 0.3-1.5mm의 입자 크기를 가진 아타풀가이트나 버미큐라이트 같은 과립담체에 포함시켜 제조할 수 있다. 활성물질의 어떤 원하는 농도로 물이나 기름에 현탁될 수 있는 습윤분말제는 습윤제를 농축된 분말조성물에 포함시켜 제조할 수 있다. 어떤 경우에 활성화합물은 석유 또는 키시렌과 같은 보통 유기용매에 충분히 용해되므로 이들 용매에 용해된 용액 상태로 직접 사용할 수 있다. 때로는 제초제의 용액을 에어졸로서 초대기압하에서 분산시킬 수 있다.Substantial use as a preparation compound of the present invention is generally made of a preparation composition consisting of an inactive carrier and a manufacturing active capacity of such a compound. It is to be applied to the weed propagation place by the desired amount as a preparation of such a preparation composition. These compositions may be as solids such as powders, granules or wet powders or as liquids such as solutions, aerosols or concentrates which may be emulsified. For example, the problem can be prepared by mixing and stirring the actives with solid inert carriers such as talc, claysilica, propylide and the like, and granules are usually dissolved in attaful solvents in a suitable solvent to form atapules with a particle size of 0.3-1.5 mm. It can be prepared by incorporating into granular carriers such as guides and vermiculite. Wet powders, which can be suspended in water or oil at any desired concentration of the active substance, can be prepared by incorporating the wetting agent into the concentrated powder composition. In some cases, the active compounds are sufficiently soluble in common organic solvents such as petroleum or xylene and can therefore be used directly in solution in these solvents. Sometimes solutions of herbicides can be dispersed under superatmospheric pressure as aerosols.

그러나 바람직한 액체조성물은 본 발명의 활성물질과 불활성 담체로서 용매와 유화제로 구성된 유활될 수 있는 농축액이다. 이러한 유화될 수 있는 농축액은 잡초만연 지역에 살포적용하기 위해 원하는 활성물질 농도만큼 물이나 기름으로 희석시킬 수 있다. 이들 농축액에 사용되는 가장 일반적인 유화제는 비이온계면 활성제 또는 비이온과 음이온계면 활성제의 혼합물이다. 유화제를 사용함으로서 잡초가 만연된 곳에 직접 사용할 수 있도록 전환된 유화액을 제조할 수 있다.However, preferred liquid compositions are lubricable concentrates consisting of a solvent and an emulsifier as the active substance of the present invention and an inert carrier. These emulsifiable concentrates may be diluted with water or oil to the desired concentration of the active substance for application to the weed spread area. The most common emulsifiers used in these concentrates are nonionic surfactants or mixtures of nonions and anionic surfactants. By using an emulsifier, it is possible to prepare a converted emulsion for direct use where weeds are rampant.

본 발명에 의한 전형적인 제초제 조성물은 다음 실시예와 같고 여기서 용량은 중량부이다.Typical herbicide compositions according to the invention are as in the following examples where the dose is parts by weight.

[실시예 36]Example 36

분제의 제조Preparation of Powder

실시예 5의 생성물 10Product 10 of Example 5

분말 탈크 90Powder Talc 90

상기 성분을 기계적인 그라인더-혼합기에서 혼합하고 균질이 될 때까지 갈면 쉽게 유동될 수 있는 원하는 입자의 분제가 얻어진다. 이 분제는 잡초만연 지역에 직접 사용하는데 적당하다.The components are mixed in a mechanical grinder-mixer and a powder of the desired particles is obtained which can be easily flowed up until homogeneous. This powder is suitable for direct use in weed spread areas.

본 발명의 화합물은 당분야에 통상의 방법으로 제초제로 적용될 수 있다. 잡초억제에 관한 한 방법은 잡초만연 장소에 활성성분으로서 그 잡초에 제초작용을 나타낼 만한 용량의 본 발명 화합물과 불활성 담체로 구성된 제초제 조성물을 살포하는 것이다. 제초제의 조성물 중의 본 발명의 신규한 화합물의 농도는 제형이나 사용목적에 따라 아주 다양하지만 일반적으로 제초제 조성물은 본 발명의 활성화합물의 중량으로 0.05-95%를 함유한다.The compounds of the present invention can be applied as herbicides by conventional methods in the art. One method of weed suppression is to spray a herbicide composition consisting of an inert carrier with a compound of the present invention in an amount that is capable of exhibiting herbicidal activity on the weed as an active ingredient in the weed spread area. The concentrations of the novel compounds of the present invention in the composition of herbicides vary widely depending on the formulation or purpose of use, but generally the herbicide composition contains 0.05-95% by weight of the active compound of the present invention.

본 발명의 더욱 바람직한 유형의 제초제 조성물은 약 5-75%의 활성물질을 함유한 것이다.More preferred types of herbicide compositions of the present invention contain from about 5-75% of active material.

본 조성물은 살충제, 선충제 등과 같은 다른 살균제, 안정제, 분산제, 활성억제제, 접착제, 부착제, 비료, 활성강화제 등과 같은 부가적 물질을 함유할 수 있다.The composition may contain additional materials such as other fungicides, stabilizers, dispersants, active inhibitors, adhesives, adhesives, fertilizers, active enhancers and the like, such as insecticides, nematodes and the like.

본 발명의 화합물은 다른제초제 또는 고사체, 성장억제제와 전술한 제초제 조성물에서와 같은 것과 혼합할 때 더욱 유용하다. 이들 기타 물질은 제초제 조성물 중에 활성성분의 5-95%를 함유할 수 있다. 이들 제초제 또는 고사제 등을 본 발명의 화합물과 결합 사용함은 잡초억제에 더 효과적인 제초제 조성물을 제공하고 때때로 개개의 제초제로서는 얻을 수 있는 결과를 제공하게 된다. 잡초는 원하지 않는 장소에서 성장하는 원치않는 식물이고 경제적 가치가 없고 경작물의 생산, 관상용 식물 또는 목축의 번식을 방해하는 식물이다. 잡초에는 명아주류, 램브스쿼터, 뚝새풀, 왕바랭이속의 식물, 야생겨자, 필드페니크레스, 독보리속의 목초, 갈퀴덩쿨, 별꽃, 야생귀리, 벨빗리프, 쇠비듬, 반야드그라노, 여뀌류식물의 일종, 마디풀, 도꼬마리, 야생메밀, 코치아, 개자리속의 식물, 콘코졸, 랙위드, 방가지똥 코오피위드, 파두, 쿠피아, 새삼속의 풀, 현호색류의 풀, 개쑥갓, 헴프네틀, 나웹, 등대속의 식물, 개미자리의 일종, 메멕스, 정글라이스, 가래속의 수초, 국화과에 속하는 식물속의 일종, 카펠위드, 나팔꽃, 갈퀴덩굴속의 풀, 더크사라다, 나이애드, 개보리류의 잡초, 풀파니쿰, 흰꽃독말풀, 위치그라스, 스윗치그라스, 수조, 티위드, 와일드 터닙과 스프랭레톱과 같은 일년초 ; 야생당근, 매트리카리아, 야생보리, 동자꽃, 노란양국, 우엉, 현삼과의 식물 둥근잎 아욱속, 벌티슬, 큰유리새의 일종, 모스뮤레인과, 퍼플스타 티슬과 같은 2년생 식물 ; 또는 화이트코클, 다년생독보리속의 식물, 코커그라스, 존슨그라스, 카나다티슬, 헷지바인드위드, 버뮤다그라스, 쉬프소렐, 퀴리독크, 넛트그라스, 필드치크위드, 민들레, 도라지, 필드바인드위드, 러시언냅위드콩과의 관목, 헤란초의 일종, 서양가새풀속, 해국, 그롬웩, 속새속의 식물, 아이론워드, 세스바니아, 갈대, 부들, 원터-크레스, 호스네롤, 넛쎄지, 당면속의 식물과 시콜포드와 같은 다년생물을 포함하여 종류의 잡초들이 알려져 있다. 유사하게 그와같은 잡초는 잎이 넓은 잡초 또는 풀같은 잡초로 분류된다. 유익한 식물 또는 목초의 손상없이 그와같은 잡초의 성장을 억제하는 것이 경제적으로 바람직하다.The compounds of the present invention are more useful when mixed with other herbicides or dead solids, growth inhibitors and the same as in the herbicide compositions described above. These other substances may contain 5-95% of the active ingredient in the herbicide composition. The use of these herbicides or acaricides in combination with the compounds of the present invention provides more effective herbicide compositions for weed suppression and sometimes results obtainable as individual herbicides. Weeds are undesired plants that grow in undesired places and are of no economic value and interfere with the production of crops, ornamental plants or breeding of livestock. Weeds include wild liquor, lamb's quarter, nectar, wild grass, wild mustard, field pennyless, poisonous grass, rake, chickweed, wild oat, belbit leaf, purdure, vanyardgrano, a kind of perennial plant, Barkweed, Docomari, Wild Buckwheat, Kochia, Canopy, Concosol, Rackweed, Frog Coopweed, Padu, Coupia, Cactus Grass, Corydalis Grass, Gazette, Hempnet, Naweb, Lighthouse Genus, trefoil, memex, jungle rice, herbaceous plants, asteraceae, chapelweed, morning glory, rake grass, dirk salad, nyad, barley weed, fulpanicum Year-round, such as datura, witchgrass, witchgrass, fish tank, tiweed, wild turnip and sprenkle top; Wild carrots, matricaria, wild barley, cauliflower, yellow-headed radish, burdock, hawthorn, biennial plants such as round leaf mallow, vulture, marsupial, moss murinein, and purple star thistle; Or white cockle, perennial barley, cokergrass, johnsongrass, canadatis, hedge bindweed, bermudagrass, chivesorel, quiridok, nutgrass, field cheekweed, dandelion, bellflower, field bindweed, rushonnaedweed Shrubs, herbarium, horsefly, hydrangea, grompon, genus plants, ironward, sesbania, reeds, buds, winter-cress, hosnerol, nutsage, perennial plants and perennial plants such as sicopod Kinds of weeds are known including water. Similarly such weeds are classified as broadleaf weeds or grassy weeds. It is economically desirable to inhibit the growth of such weeds without damaging beneficial plants or grasses.

본 발명의 새로운 화합물은 많은 유익한 식물에 비교적으로 비독성인 반면에 많은 종과속의 잡초에 독성이 있기 때문에 특히 잡초억제에 가치가 있다. 필요한 화합물의 정확한 량은 특정잡초 종류의 강도, 기후, 토양의 종류, 적용방법, 동일지역에 있는 유익한 식물의 종류 등과 같은 여러가지 인자에 좌우된다.The new compounds of the present invention are particularly valuable for weed control because they are relatively nontoxic to many beneficial plants, while being toxic to many weeds. The exact amount of compound required depends on several factors, such as the strength of the specific weed species, the climate, the type of soil, the method of application, and the types of beneficial plants in the same area.

그래서 에이커당 활성화합물의 1-2온스까지 적용은 역조건하에서 성장하는 잡초의 경매한 만연을 억제하는데 충분하고 에이커당 활성화합물의 10파운드 또는 그 이상의 적용은 호조건하에서 성장하는 끈질긴 다년생 잡초의 조미할 만연을 억제하는데 필요할 수도 있다.Thus, application of up to 1-2 ounces of active compound per acre is sufficient to suppress the auctioned rampant of weeds growing under adverse conditions and application of 10 pounds or more of active compound per acre is a seasoned perennial weed that grows under favorable conditions. It may be necessary to suppress the rampant spread.

본 발명의 새로운 화합물의 제초적 독성은 발아전 또는 발아 후 시험과 같은 많은 공지의 시험기술에 의하여 설명될 수 있다.The herbicidal toxicity of the new compounds of the present invention can be explained by many known test techniques, such as pre- or post-germination tests.

본 발명 화합물의 제조제적 활성은 여러가지 잡초의 발아전 억제를 위해 행한 실험에 의하여 증명되었다. 이들 실험에서 건조흙으로 채워진 조그만 프라스틱 온실화분은 여러 종류의 잡초씨를 뿌렸다. 화분에 씨를 뿌린 후 24시간 또는 그 이내에 흙이 젖을때까지 물을 뿌리고 유화제를 함유한 아세톤용액의 수성 유액으로 만든 시험화합물을 토양의 표면에 지시된 농도로 분무하였다. 분무 후, 토양용기를 온실에 두고 요구되는 열을 공급하고 매일 또는 가끔 물을 뿌렸다. 식물은 21일 동안 이들 조건하에서 유지되었고 그때 식물의 상태와 식물에 미치는 손상의 정도는 다음과 같이 0-10의 등급으로 평가되었다.Preparative activity of the compounds of the present invention has been demonstrated by experiments conducted for the inhibition of germination of various weeds. In these experiments, small plastic greenhouse pots filled with dry soil were sprayed with various types of weed seeds. After seeding the pots, water was sprayed for 24 hours or less until the soil became wet, and the test compound made of an aqueous emulsion of acetone solution containing an emulsifier was sprayed at the concentration indicated on the surface of the soil. After spraying, the soil container was placed in a greenhouse to provide the required heat and watered daily or occasionally. The plants were kept under these conditions for 21 days and the condition of the plants and the degree of damage to the plants were then evaluated on a scale of 0-10 as follows.

0=손상이 없음, 1,2=조금 손상, 3,4=보통의 손상, 5,6=좀 심하게 손상, 7,8,9=심한 손상과, 10=고사0 = No damage, 1,2 = Slight damage, 3,4 = Normal damage, 5,6 = Severe damage, 7,8,9 = Severe damage, 10 = Test

화합물의 효과는 다음 표(I)에 나타난 데이타에 의하여 증명된다.The effect of the compound is demonstrated by the data shown in the following table (I).

본 발명 화합물의 제초제적 활성은 여러가지 잡초의 발아 후 억제를 위해 수행된 실험에 의해서도 증명되었다.The herbicidal activity of the compounds of the present invention has also been demonstrated by experiments conducted for inhibition after germination of various weeds.

이들 실험에서 시험될 화합물은 수성유액으로 조제되어 일정한 크기의 잡초 잎에 지시된 용량을 분무하였다. 분무 후, 식물을 온실에 두고 매일 또는 자주 물을 주었다. 물은 처리된 식물의 잎에는 주지 않았다. 손상의 정도는 처리 후 14일에 측정되었고 전술한 바와 같이 0-10등급으로 평가하였다.The compounds to be tested in these experiments were formulated with aqueous emulsion and sprayed with the indicated doses on the weed leaves of constant size. After spraying, the plants were placed in a greenhouse and watered daily or often. Water was not given to the leaves of treated plants. The extent of damage was measured 14 days after treatment and rated 0-10 as described above.

이 화합물의 효과는 다음 표(I)에 나타난 데이타에 의하여 증명된다.The effect of this compound is demonstrated by the data shown in the following table (I).

[표 1]TABLE 1

Figure kpo00037
Figure kpo00037

Claims (1)

다음 일반식(V)의 화합물을 묽은 수성산성 반응매질 중에서 가열하여 일반식(II) 화합물을 제조하거나 다음 일반식(II) 화합물을 촉매량의 톨루엔설포산 존재하에 50-90℃에서 다음 일반식(II)인 산무수물과 반응시키거나 다음 일반식(II) 화할물을 산수용체 존재하에 10-30℃에서 다음 일반식(IV) 화합물과 반응시켜 다음 일반식(I) 화합물을 제조하는 방법.The compound of formula (V) is then heated in a dilute aqueous acidic reaction medium to prepare a compound of formula (II), or the compound of formula (II) at 50-90 ° C. in the presence of a catalytic amount of toluenesulfonic acid A method of preparing the following compound of formula (I) by reacting with an acid anhydride of II) or by reacting the following compound of formula (II) with a compound of formula (IV) at 10-30 ° C. in the presence of an acid acceptor.
Figure kpo00038
Figure kpo00038
상기 식에서 R1은 알킬, 알케닐, 할로알킬, 알콕시, 알킬티오, 알킬설포닐, 알킬설피닐 또는 싸이클로알킬이고 R2는 알킬, 알케닐, 할로알킬 또는
Figure kpo00039
이고 R4와 R5는 각각 수소 또는 알킬이고 R6는 알킬, 할로알킬, 알케닐, 알키닐, 알콕시알킬, 싸이크로알킬 또는
Figure kpo00040
이고, X는 알킬, 할로겐, 할로알킬, 니트로, 시아노 또는 알콕시이고 m과 n은 각각 0-3의 정수이고 R7과 R8은 메틸 또는 에틸이다.
Wherein R 1 is alkyl, alkenyl, haloalkyl, alkoxy, alkylthio, alkylsulfonyl, alkylsulfinyl or cycloalkyl and R 2 is alkyl, alkenyl, haloalkyl or
Figure kpo00039
And R 4 and R 5 are each hydrogen or alkyl and R 6 is alkyl, haloalkyl, alkenyl, alkynyl, alkoxyalkyl, cycloalkyl or
Figure kpo00040
X is alkyl, halogen, haloalkyl, nitro, cyano or alkoxy, m and n are each an integer of 0-3 and R 7 and R 8 are methyl or ethyl.
KR7502005A 1975-09-10 1975-09-10 Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones KR810000003B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7502005A KR810000003B1 (en) 1975-09-10 1975-09-10 Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7502005A KR810000003B1 (en) 1975-09-10 1975-09-10 Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones

Publications (1)

Publication Number Publication Date
KR810000003B1 true KR810000003B1 (en) 1981-01-31

Family

ID=19201450

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7502005A KR810000003B1 (en) 1975-09-10 1975-09-10 Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones

Country Status (1)

Country Link
KR (1) KR810000003B1 (en)

Similar Documents

Publication Publication Date Title
KR850001951B1 (en) Process for preparing n-arylbenzamide derivatives
US5134145A (en) Pesticidal pyrimidinyl benzoic acids and esters
KR800000505B1 (en) Process for preparing thia diazolyl-imidazoliinones
US4319026A (en) Heterocyclic-substituted hydrazides and hydrazones as plant growth regulators
US3437664A (en) 1,2,4-oxadiazolidines
GB2043062A (en) N-(heterocyclyl)-acetanilide derivatives and herbicidal and plant growth regulating compositions containing them
KR810000003B1 (en) Process for the preparing 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones
CA1075482A (en) Method of controlling sicklepod in soybeans
US4346225A (en) Herbicidal 2-methylamino thiadiazolines
KR800000506B1 (en) Process for preparing 1-thiadiazolyl-5-acylimida zolidiones
CA1060022A (en) 1-thiadiazolyl-5-acylimidazolidinones
EP0034010A1 (en) Substituted thiosemicarbazones and use as plant growth regulants
US3981714A (en) Cyclic N-thiadiazolyl-(2)-carboxylic acid compounds and herbicidal compositions
IL44428A (en) 3-alkyl-1-(5-substituted-1,3,4-thiadiazol-2-yl)-5-hydroxy-2-imidazolidinones
US4199346A (en) Herbicides based on 2-dibenzofuranyloxyalkanecarboxylic acid derivatives
CA1146945A (en) Regulating growth of plants with phenyliminothiadiazolines
JPS5810386B2 (en) Method for producing novel thiadiazolyl imidazolidinones
CA1049522A (en) 1-thiadiazolyl-6-acyloxytetrahydropyrimidinones
US3900484A (en) 1,2,3,5-oxathiadiazolin-4-one,2-oxides
US3944409A (en) Method of increasing the yield of plants having storage organs by treatment with thiadiazolylimidazolines
US4584376A (en) 1-heterocyclicthio-1-cyclopropanecarbonitriles as crop protectants
KR790001256B1 (en) Process for preparing 1,2,4-triazoldin-3 ones
KR800001513B1 (en) 1-thiadiazolyl-5-alkylamin arylamino and cyeloimino substituted imidazolidinones
JPS5939882A (en) Novel triazine chemical synthetic substance
US4272284A (en) Arylthioureidoisoindolines and use as plant growth regulators